Enbrel® (etanercept) 50 mg/ml solution for subcutaneous injection (Bundle) - JSON Representation

Miscellaneous ePI Test, published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cander2/epi-test/ and changes regularly. See the Directory of published versions
: Enbrel® (etanercept) 50 mg/ml solution for subcutaneous injection (Bundle) - JSON Representation

Raw json | Download

{
  "resourceType" : "Bundle",
  "id" : "bundlepackageleaflet-enbrelsolution",
  "meta" : {
    "versionId" : "1",
    "lastUpdated" : "2023-08-16T00:00:00Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"
    ]
  },
  "language" : "en",
  "identifier" : {
    "system" : "https://www.minzdrav.gov.ru/",
    "value" : "enbrel"
  },
  "type" : "document",
  "timestamp" : "2023-08-16T00:00:00Z",
  "entry" : [
    {
      "fullUrl" : "Composition/compositionruen",
      "resource" : {
        "resourceType" : "Composition",
        "id" : "compositionruen",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"
          ]
        },
        "language" : "en",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><a name=\"Composition_compositionruen\"> </a><p><b>Generated Narrative: Composition</b><a name=\"compositionruen\"> </a><a name=\"hccompositionruen\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Composition &quot;compositionruen&quot;  (Language &quot;en&quot;) </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Composition-uv-epi.html\">Composition (ePI)</a></p></div><p><b style=\"color: maroon\">Exception generating Narrative: unknown extension http://hl7.org/fhir</b></p></div>"
        },
        "contained" : [
          {
            "resourceType" : "Binary",
            "id" : "image1",
            "contentType" : "image/png",
            "data" : "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"
          },
          {
            "resourceType" : "Binary",
            "id" : "image2",
            "contentType" : "image/png",
            "data" : "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"
          },
          {
            "resourceType" : "Binary",
            "id" : "image3",
            "contentType" : "image/png",
            "data" : "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"
          },
          {
            "resourceType" : "Binary",
            "id" : "image4",
            "contentType" : "image/png",
            "data" : "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"
          },
          {
            "resourceType" : "Binary",
            "id" : "image5",
            "contentType" : "image/png",
            "data" : "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"
          },
          {
            "resourceType" : "Binary",
            "id" : "image7",
            "contentType" : "image/png",
            "data" : "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"
          },
          {
            "resourceType" : "Binary",
            "id" : "image8",
            "contentType" : "image/png",
            "data" : "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"
          },
          {
            "resourceType" : "Binary",
            "id" : "image9",
            "contentType" : "image/png",
            "data" : "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"
          },
          {
            "resourceType" : "Binary",
            "id" : "image10",
            "contentType" : "image/png",
            "data" : "iVBORw0KGgoAAAANSUhEUgAAANQAAACQCAYAAABwF0ViAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAAJcEhZcwAADsQAAA7EAZUrDhsAADOGSURBVHhe7Z1pUJtXmu/v5/k0NTVTNVM9NXWn6t6qe+9Mp3uW6k4n3e2kEzubkziOncTpOHESx/uCWWyzY/YdzA5CQiAQi1glkMSOxCL2HYl93/fNGBs7/3vOQcTYxo5tjJDI+6s6Jd6XVxJI7/88z3OW5/kf2IP8+COgUjUgMkrKWhRP9niLkiEiIgu5uVW4d+++/pkcHNtjTwoqNCgV//qvX+Drv7rAyiwIVy4EPNaszG7i2+Nu+Jd/+Rx2tjzcv8+JimP77ElBvfOOGfa/fQV3V+/ozzyZr4654rVXz+POnbv6MxwvG9pZzc0t6I/2NntSUJLUAvzmlRP4+CNr/JVYqa++cmXtm288cOiQHQ4etGbtnXcs8Y//eAiHDzvon8mxEwwOTuDkD87o6BzQn9m77ElBUZqaOsHnk/gpKgsCgQzW1hH4m795F+fOBcDBIYY1R0chXn31HL744gaqqnQQxcrR0NCGmZlfRm/6Mrh9+zb5vOb0R1uTJsnHlcs+EMXkEGtFAtwnMDe/iKWlZf2RabJnBfUovb1j+Nu/PYjS0mZMTc3/1I6TOIpaq+npBZSqG5GvLEXYzWTc9BcjT1kBrbYX9+koB8eWtLT04sintqiu1OrPPMzExAw8XQWYmpyDu2sM+R5G9b95mMrKNpw940E6tmb9GdNkzwtqeHgSUqkKV6+G4e///mP80z99il/96gj++Z+PsvYP/3AIv/3tSQQEpCApOY98sc1MXJOTM1CpahEakoJgIrCSolosLd7SvyrHBhUVbfjhey+EBSUiKSlPf/YBCfEKpBIXnCKXlxIvIJv9vBmptAg2NpHw942HWl2nP2ua7ElB9faOMHfv+HEnfPaZE06ccIHbDT5KSurR2NiN7u5RtLcPoKNjCJ2dw6x3jIpKh7l5AL788gZxAR1hfT0calULlpdWMEJEKUnJhasrDzk5ZVhc4oS1QUlJE3x8krBCXD9vbxF8iSiWl9c/n4nxWXg6x2B4aJIdz88twd05mngGs+x4efk2+JEZCPQTs58LCytRXFzFfmeq7ClBNTZ2wcoqFG+9dQmXLwchM1OFvr4R4uMvkp60EQkJCgQFpcHHNxlOTgLcuCEkN0AyOZdKri0i8VMHxslNUFvTAkG0DJ8ftWMDG0Khgnzhq1hYWEJ8Qg58vGNRqWnRv+svG9oZubuL9EeAWJxLXLxojAxNIDdXQ+JXqf436yQn5yIttZC4gvPkcxRCFCfH/Xvrv0tLk6O5uX39wETZE4IaG5shQgrDgQNm5MuNw8jIJAYHRomrUYyTJ93xERHFoQ9tcPQjO5z81guXLwYhPDyNuSLh4RK4uAhw/rw3GxE8ctgO5pcCUFRcx8RYUdaCb792w/vvWBHRqdn7DQ+Pw4/0xMLYLCIy0w6it0tX1yDxBjIfmhxXq5pgZxMCs/NepIOa1p9dZ2Roinz+frh4wRuq4lr9WWBtbY18vkr09PTrz5gmJi+obGkZ3iFCunAhgLhyQ8yVs7PnYf+bZjj8kS0cbWIgjslDkaIe5YWtqChqQ1l+Cwb7J/Sv8IBbt1ZRX69DRIQUn3/ugE8OXUdkWAYmp+ZQUFCDDz+8ygQ5Pj7Drk9JKoCvlwhDw1PseK8ilaqRLVu39ouLD3cgA/2jiI2VPbbapKOjH+qSreMh6ia2tHTpj9ahgsrKyiWCenhofX5+Gd09w8iRlZKmJu+jN2dGiskKam3tHpwdY/DGvotQKMrZ0K2rSwxe/8NZfPVXV8Tx81FW0Iya0g4mJFVuE2mNKFE2ojCnHp3tQ/pX2pq7d+9CparD99+74Z395sQdUZEvd4nEVkSs+69AU97ErtOUNsLVmY++LQS6V4iIkODU9y4Q8qQkXopFcko2ZKQj02n70NrajZgY6bZXmty5cwcSiQw6XSf5bgagyKlAWooSXqTDCglJw/XrgcRFFOFHIx9xNUlBrd6+g7Pf++KT963R3zeGqiotucmJRTpki/iYXFSW6JglUuc1MwE92h4VFBXnBosLjw845Cmr8cH7Vjh3zov4/nPIylBj32unIU0vYb9vqNUScfOI+zPMjvcao6NT8PTkY3p6nljx2yRW1RLrnI8kcQ4cHCLh6BhNBLU9y0EtlItLJIltw9nrihNy0Virw63l25iZXoCTYxR5/6fPdxkDJieolZW7OPmNF748cgOrq3dJEFyAV37zPa5ZRTFLVFms3VJEmxsVVFfH+s1fUlSNeFE2RonbFh6WgvOnPHDDKZJYo4cnd++u3YUD+VL377eArm0QpcSdeeP108hILWK/r65ugfuNaMzNzrPjvYZSXoboyHT90To//nifub/rE+Hbtxyzs4skHp5+TJzhIemQJBbqj4wbkxOUuUUIjn3hRHq0+4iIzMJ//PYHhN/MRJW6HaVPsEiPNur+NTf2EHciHvv+dJH1vmaXAmBnG05isD6cPesJb+9Y/TsCc3PLKCqqQW2dDmEkpvo9ec/qyg4SVDfiv//7B1RUrI/4SbNU8PePfwm3lvFBXTJn+0i0ND8c++w0nZ39xHLxsGAic4AmJSg+X4a3377Mhq9Fcfl45dffIZanQA0Rk0rZtKV4tmrF8gZoW/vR1tYLH994WFn54uhn1sR/H2Tvk5+vwVdfubCfR0amcfy4M06d8sWnh+0RQK6nQ72vv36ePH8AiaTnfP21cxgeXJ9rCQwQoyDftOdSnkRTYwf5/0WkMzPMQmLqigcGxqOsrEF/xvgxGUFpSQD8h9+dQTWJlzSaFvz6375BWFAmqtW6LUXztMZiqI71GCozsxDnz7vj2rUAEh+tD/FWV+vw2Wf2WFxcINZLhEuXbrLzA/1j8PGMZa4mj5eB99+3YKNQdrYROHfGh10zNDgBJ2Lp6FKbvYifn4jN7xmCstIG+HrF6Y9MA5MQ1J079/DlX52JGybG4vwt/OWNy3Cw5hMxEctE3LetRPO0tnlQQiLJw4UL7jh92hXDw+sjdZWVrWzFxPz8PK5c8oEsfesb6MLFQCa26Zk5HHjHDBkZ64MUifFyJCUq2c+mDP3ch4fH0FCnRVJSIeJi5PDyjIaIxJyGIFWSDz/fWAiFOYiLU6K+XouBgRHSof38tpzdwiQEJZOV4y9vXiIWYwmODtH4+EMblBe1oTT/2WKmR9tmQSUlKeDoGIpPPrEmrt76RKMwVoaTJ73ZEK2tTRh5TwE7Pz09AycnPvr6xtDdNYAUcpP94Xc/oLS0EWmSYhx42wyrd+4SIS6S66KwtLjCnmdK0OHv5GQl7Owi4O4eTz4fOaTEimdnl0Nd0oARIjA6pWAI7t5dY5PopcRSpaerkZNTTISVQaxkEhxtI5GSkou7a2v6q40DoxcUHfE5fvwG+FEydHUP4dVXT0MkUELzDKN5T2qbBRUbm4WQkETy5RThyBEbuLrG43PyWFRYzX7f1NyNDz6wgr09H6e+88C7By4hNiYbElEhKopaYWsRgUMHrbG8tEzcRDuIxfnsebExUihyytnPpgTtREQiOb791hnl+rm2rbmNluIm6PpJp3F/EdWKZows3sfa7BjKlDrMv+B9PtWtRUHDIJ42CF9R0YozZ9wRE0MnlI1rotfoBVVW1oj3SM8/N7sMC4sQfP2VCypLtFBtIZRnbZsFRRdqbiyPUaub2Lq9psaHR7KGhiZhYx2Bw4euwYv02vJMDbGOLWzFRW5WNfbtuwQZ6cFTUgrw1VfObDi5tlqL8BCJ0U9EPolm0pF4egqRSFzX27dX9Wc3M4PQk4EQ5owDa31wOBwEVd9dLOvKceUIH50vOCjXmBqN4z65uLPFx0bnH1NS8uHiEo22th79WePC6AXl6CiAC3GzhobGWewkiFSwSduthPKsbbOgfg6drg9BQUmwt4lARnIJygpamZg2XouK29IiHGfO+rMRQTrB3NDQyQYu+IK0nwY6TJGVldtsWZGTU8RjS4WAWfDNIpCYP0kENQDPb6JQMXAXtzqrYPdtAgaI4Vgd7oTgZhKCRdWYoRZrbQa5/HR4esTDzV+GYu0gmgtr0Tm1hrnOFqRlt0GTJcb5kKLHBNXRMQgfr1hERWWyUV5jxagFRXdvfvihJXE9WpGZVYYD+81RJK9/4dhpoz2LoAb7x+DmIcSxLxzh7SJCkbIBFYWPC5mKOzm2CPtev4Dmlm6YmwchNDSTvYYHsWYa4p6YOlXVreRmFiCTxDHLyxtx4ZMF5XAyBT0TAwi94g0bv2Q4mvvCLbEDt+fbcP2D63AJycKVU84wE+aDZxYCWX0fhLYesBE2oi1PArPIEtzVC2plZRX5uRXw8IhBba3xr/A3akG1tPST+MWCWKdRXL0ajCuXQlFd+vzD5I+2pwmKWhQPdxHeOWCBs6d9kSUpY/Hak5YxrU8m1+Pg+9dI0FxJAvpinD7twV4rTVKIwoK9MSdVVlZPOjdzdHZufG5PFtSNs+nkc8nCl6dj0HPrLnqUGTh5XIz2YS0CL/LRdRtQpSbCOqEYiTd4CPCNwzX7ZAyQ8+O1Cvhk12FjZeDIyDi+ILGpqcztGbWgZLIyEnz6YX5uAe+/a4ZAnxRUq9ofu6mft20lqJnpeWJZJPjjn87ivf2WiAyVMXeurOCBe7dVoxPK1Sodzv3gD19fMcpKG/HJISvWszY3ayFXFOvfwTS5c2cV8SIlPN2j0dTcuWlV+bqgkgqmgHuD8PqGB83gGla6quF6IR3KNDHe+8gaZlejYHk5GK5Bxegd1ML/fBRaZteQJ06AbXIp4i3s8ev/eQYe8euWfKxeAV/FA0HRGLSpqRvuznzydyhwi3yuxoxRCyo0NBnW1jzMzCzhzb+YQRxbsKXb9byNCqqvZ4y9x9LSCokTcvDnP13AK/92Ava2fHJNA1sT+KxzXDXqDjjZCHD+tBfatT1EUFcxNj7LeleRSLbtldi7BY1b/PziSAwp2SIN2LqgJCq6+3YYPt/yUDP2I+7118LtfAbU+TJ8fTkZdGPLSr8OmZJmjI9r4XkyXC+oeFwXF0PsGAF/Lz7MzGLRPn8fqyMdULcOP7Z8i05BCKIz4eoWzZYjGStGLagbDlFwc41DT88IPvzIFgpp9TOv13tao0uPGus7kZWpxttEqL/61WF8+aULMpPVqCLW5nnfg1qyAO9kHDlih8HBYRw75ojOjmEW1IvFOfr/xnSgHUB2dincXfmormzTn32UeUSedsSho95wcvDGW789ixNXwmF33g5//LMn5PUdiLELgqUtDxe+c4OLqB41GQlEOBmYu/8jpAIBzEkMxb8SguzGfsRd84BFVB366jWIzW5+4rB5TU0bfHzikJGhYivUjQ2jFpSFeSCiwtPRTnrKjz62RW729gVFn5+fU4u/fumEv/u7D4hluoiwwAxUFLcR69e65XN+rmmK2sALk+LAu5aYmprD2bN+KC9vgVBI1/ydgVxeof+PjB86aevhIcTXX9ujqrKFWKalJwybr6GntgHiGCViRQVISilGQnweW0Xx7Q+ucM4mVmRhGLKEXEjyOkHCI4y16qAbWrd0I719aOqfQC8R3vDCPSwMdKG4qh+jgz0obxv5yeXbDP076J602tp2fH3cAa6uApbGzJgwakFdtwwGL+KBoJSy7QuKzl/RAYYbxEWzvBRCRFqDKmJh1C+whGmjUUFFhWZi/wELTEzO4tQpH5bnr7CwBn/+41k0NppOngSaN6+quoV0AiUIDkyBp2c86RjSiEXIJ49KtLR06698MvKkRAQp+/RH22NoaAo8noy9v0iUCU+3WPj7J0MuU7MMVZv3shkDRi0oV0ce3NzWXb6PiMv3MgS10ehgA13pQCdnt/r98zS6odHfOwmHP7XBQD9x+b5wgFa7vnJ9Y9+VqUIHBcbHp9DW1s1ydPj7iSHNWl+zuDX3sTQ7h7nF7a+3KyysAJ+fxd6XdkoTE1NGJ6BHMfJBiRTY2ERjepoOSlxBYlwBygu2PyhB2/qW+Be3SpsbHZSgFo8OSmhbe/DRQSuWfngv4uXGZ6vADUFdnQ4eLnz9kWlg1ILKySkn8Yg/W2x68EOLlzZs/jIbGzZX63D+lD+8vWmixgZ8/LEl5ucW9f/F3kGhKEN4qER/ZBjCgtOQSuIzU8GoBdXePohPPrnKthBYWgXB/HIYakqNS1DUBVXlNuDDD65DmVsNiUSFixf92Xq+vcQc6SBs7UJZijZDQrfEuznzMU4eTQGjFtStW7fw2WfXUVzSzJbv09ULxYrtLz16mY0tPRIV460/XYKurYdln42MlOn/g72DOEGBtNT1lfQbTE7NEovczLLxbncRMH16m7YfNTVaIqKH07JlZRUjOvrhfBbGilELiuLtmYAbTnz0D4zizX2XIYxSbntx7MtsdALY0iwMp8/4EUs6iYMHr6ChwbSznz5KS2svbjhGs9TKnR19xAUrgICXiThhBrHGN+HkxNv2Noo7q3fh5S6Ao2MkBIJU8HhpSErIg1bbg9HRGbi68qHTGX8STKMXVC3psfa/bYbZ2WVYWoTixNeu296+8bIaXXWeJ63BG3++BLm8HGJxHr75xp0NPe8lgvwTceIbF5ZyWZwghVJRjpambiwtLpObfRLx8TmPJbp8Xuj8V1ZGLnEpx7CyssLy/eUpNYiLk8HFJRZnz3jCzVVg9KtOjF5Q9AOkKZJ5vCzQBIh/ePU0EoR529pg+LIaTQ5jbRWFo5/S/BPL+PRTWyQm5ur/8r1Dc0MHW+5D1yc+Sl/fMLvpHxVUXl4N6Nb1raAdD834u5n1zLFKdHU9Pn9F88rrtL1oZWsJuWHzbSOXV7JsR3TW3tGWh48/tEZ5UctLm5N6kaYp0iJTUoY//OEsykqbkJpaRNw9iy1vur0M3S9G88RvWA5aWpXu+KWpv5ycwtDxyLo7mmnq+vUQlm03LlbBrqes5zZXPJaK2dQwCUHRgPfUKU+4uAoxT1y/t968BEc7fZKW50gf9rIaHRRR5zfh8Mc2ML8SyrLJvk3cUpr74peGStXEKkFSaJJPHx8hKw1E8/hVaprBi0hjv6PQ7zEiPB3ybA07TiDCc3ePYYXvKJmZBaipMe39YyYhKEpHB3H3fn+arZHTaJrwm9+cQESoDFUvkEZsO40uW6LzTubng/DBexaYnJyDpVkwLl7w1/+lvyzoKJ+PTzLGxibhZB9BLPWDDK+0TpSfdxza9fkOB4cmSBwUzbayb5CTo4Y9eV53dz+Ki2tQWMjVhzIY8aJc/GXfRYyTQDghPh//8cpJxPKUqC3r2PLmf9mNiokOiNhZ8Zirp9X1I1agwBt/vszyf/8SqazU4oMPrsPfX0Ssy+Ojm+mpKuLarU8jiIQySKWPT9LS/BW2tmGwtAwgAn1Q4sYUMSlBUW7Y8/DJIRu2P4YfLcNvXvkeYQEZqC599lTML9Jo3nRNUSssLobg9dfPob6+B1KZBq///gxxbbauL/tLQNc+CEvzYIwObz3hu3JrlVXs6OjohZ+XENOT69ULH2VoaBoeHrFobOzQnzFNTE5Qt1bu4NKlIBz84BrGJ6ZY+q//JKKytopAGYltnqVYwPM0dW4zG82Tp1fir5/dwP63zclNNIyMDDV+97tTyM1bTzdmDNDtDTThPivIPb1A2vojzW67tkOjY88yRVCYr8Ghg1eQnPzwxPBWbHf4fbcxOUFR7txZw4WzgThwwAIDA2OordHhvXfNcegDG8QRF5BuEnxaOZtnaXTggYqzNL8JXu6JePXV8zAzCyQingOPl43XXjsFufzhod/doq6+A34+YnxxxB4H3rTAewcsSbNi7Z23zPH+fiuc+t4DMTE5P2XHNSTTU3Nwd+JjZNh0M0A9KyYpKApdquLllYA33jiPFEkhy69Hi3O9RmKbr7+iBdfyUMoKrrWzbfPPsrKcuoxURHTQgWZXCvZJx6H3rfHuuxbE918v6mZ5JQRvvXWFuHyd+r9kd8nLryWx5Hf48+/O4tODNvjmc2ec+cYDp0mjjz8cd8NXRxxx6N1r+P1vT+Gd/Zbo6R3RP9tQ/Ij721yaZCqYrKA2oJUy3n33Cs6f92VzIjS7rLOjAG++eRkffWgN+2s8xAuUTCDUatEJYU0xfXzQ6HkqOnlWFSKCsnDlUgjefdsChz+2RmR4BhNrerqKBN/mOHfODxMTW8cBhoauLvjicwfse/USzM/64/IpX1w46YNz33ltat64SM5dPuWHSyd98cr/O4GiItOpZmFqmLygKLSy3g1HPva/ZQZn4lp0dA6jq2sAWdJS/PC9Oz4+eB2HD9nji88c8d03rrhy/iaxNOEkmA7HRfLzt8SiHT1ki48/tsGHH16HtU04VKpGdHcPQqGsxLFjTvjoo6tsO4kxUVXVjF//32/wu1fO4eBbVjj6kQ2OH72Bb4+54MQXLuyRtmPEQn3ygTXe2WeO//2/jrPEnRw7w54Q1Aa05A0tT/kuiafOnfNHaloJW1w5OTmP6hotklPymJtIk+B7eorhQZtHPMKCUpGVUcR2pdK0y2VldQgMTCUissHRo45sCY2hEuQ/DwpFKV5/7Qxe+T8niJW6iN//xyn8x7+fxKu/PY3X/vMUEdoP+K9fn8ar/3UG7//FAkeIqN7edxlHP7HBreVf1ooOQ7GnBLUBnROKj8/Hd995EEHY48QJN1y7FsJqOtENgDTZfHl5M2u0+qBUpoZ/QDwuX/bFcRJzfP6ZLRxsI1jGWppS2VgpK61CTEwmzp71wXsHLPDNsRuwsgzGTf8kRIalk/9XCjdXIT771Bp//MM5/Oe/n8AnH1qxEdKpKeNNZ2zK7ElBbYZaJ7W6BpGR6XByEuLq1QhYWYWRFs6apWUYbGx48PERszIura09bBTRFCgqqiBuqIqNdKrVdQgLSyMWNw7RYakQhKYiLCQFISEShPmL4e0ei2vXI1l1kONfe2BkZG8WhNtt9ryg9jKlpdXIzlaxXbR0LxZdBjUyMoV2XT+aGjuhqWhGWXkTmpu60NU5yIpLt7cPwNk5BktLxlu0zJThBGWk0GJjNDH/KBEIrTxCV2FXVTUyAeXklEIuL2X1Z728olmNK+r60SYUZpJjKeJiZIgXZrMWJ5Ahli9lLSgwERfPeSMtpYC8lhq+vslwc4tHQGAKS8rf1tqFhQXTKxRnLHCCMiJocbkqEt+lJCnB52fA1jYK3h4iEg9mIzExG/n5pSSua4RG08xaVVUrqqtbWX66xxr5fSWxUI829jxNC/u5grTSUvp8LbFkrVCVVEMYkwF7h2gkJyowODiu/8s4nhVOUEYAXX1dkFcJTxcBbvolQFVcC5qBdrdiucWlFeTKNaywGS27acw1bY0NTlC7jLqkFl5uMeCFp0JrZFX56LrA+Hg5cQkFqK/fW3kydgpOUAbm1q1VaLX94EXQBCe+MDfzhTy7lOXMMFaamzvh6BgBsUiBlRXjnUYwBjhBGYDVlTtQyCsR4C/GdYsAVhz7wH4znDjhAl50OqIjM3HmlCfyidtnrNCOQBSXw+ru9hp8LaDpwAlqh5meXsD5s74wu3wTMlkFWts6WWaf2dmH54G6uwZwzSoITU3Gsej2SZSX1+P69SAUFRmv+HcTTlA7jFiUjchICSLCkkkv/3S3rrmlE26O0WzI3Jjp7x+Dj2cMhMIsLC5yQ+yb4QS1g9CNfU4OUeznjLQCuLny1/edPIX4WCka64x/AIBmK0pPz2OJKVtbH60Q/8uFE9QOMjQ0weaTKLdu3YbZeR80PGW0bG3tR3a9RtOoP2P80Hkte/tw5OaaTlG5nYQT1A5CE917uQt/2tZNM6462IVhbv7hhalLS7dY/SMvrzi2woGm4DIl6Jb7oIBE+PrEY3pmPSXYLxVOUDsIFZK/fxxaSGxEWVu7ywqWnf7BAzKZCumSIvh6ixFyMxEBAWK28uFFWFu7z5Yn7TapacWwtQ4jLqtpJ1rZDpygdhiaxcfJKQLLyw9qwdaTGIkuJUqV5KMgrxZDA9sTQ3l5A3KeWlXQcLTrBuDlEQOxONfoB1d2Ak5QBiA5OQ+BgUkvfVL0FhFpcXE1y3nh5ydCX98QJifmcPv2HdZ2K4MQTfYvEGSwrLC0asovCU5QBoCm2kqKVxBLFQVtW6/+7ItBMwhVE9cwjYjU3o7H6ibRjZBKeRkSE7Lh75MAK6sIWNvwwOdlIiMtH0plFTra+3B71bAV0wsLa+HizENBQY3+zN6HE5QBKS2rR2S4BLzwdGRmlqC5QYf29i4S/4yxGGhwcGxTG0d//yja2jpQXd2IRCJIWpE9hp+G8NBU5OdqMDu7oH/lrZmamkGFphGxQgWExGKEhIoxYGCLMdA/zkQVGJjMUjPvdThB7QK06DOtx3vye1e8ue8MAgJERGCFbMdwQkIOq7dEH2mZGIWimPTwpSgsqEJTYzfm5p4sIlqGlGY0ysvTsBzhJSW15HnVqNS0Ess2zyyGjU0oenqGMNA3Co2mxSAryVfv3EFMTDZcb/CIhTb+omnbgROUAaHbMWgB5sjIZPD5MoSFS8GLkiIsNAmpyfksXdl2oIksHR34RFTVUKlqoS6tQ7a0FFbmoXC0DWfXeHsn4s03ziEiJAVp6cVsfsxQNDR0wMEhAhkZxjGAshNwgjIQHR2DuEF66OCgpMeEQ7emSzNUcLQJQ1pqwQtlWJqcnEZQQDzm57ZOvkJzwg8OjKO4sAYW5r7w9IjBj7tQaZFa2MDARISFJRlNfsOXCScoA1BZ2QoXp2jU1+n0Z7aGCo0vyIKvVyxqqtqeyx2jE8N0K/yTcHKKJRaiG1XVzVAoy1mp1anJ3UnUQldfyXMq4H4jGpryFv3ZvQEnqB2mu3uIWIfIJ1an2IrWli5EhqUiNCQRUqkK3Z0DrBDA01CrGxEaunWldFrozNc3jiVzofNDOeRmNga6Ovtx/VoYRHHZWN0j+6w4Qe0wkkQlCgtebKtDJxESrVghFKQj0C8BdnZ8WFvzYGvLIy5TKuTSElSU10HXPkQsVCf8/GLZqNqj6Np6EBeTyVxJWlFw2IhyRdAJ72heFny849DXN6Y/a7pwgtpB6EqBG/bRJG5Y1J95MagQZqbnQbPaDg5Oop+IRqfrR11tC7KzSthAAz86E6e+d8Vrvz8NAV+KNmLlBgaGWObcSxd94e0WB3//JJw/726UNZhoXkFr6xCUlNT83IJ8o4YT1A5Cs85euHjTYEPTg4OjUCiqiFUrRFZGHrJl+UhNlbNh+SRiKYsK61Df0I7AgAQIY7KxsmJci3Dp/FtUlAQODtGQSHKJuCpRW6tDc3MvS6dmCsliOEHtIFRQly8H71pl+CctPZqZXkBwYCKCgpNJbGZ8scvw8DSamtpRUFDGksTQ/POR4Wkk1spkBbHppHh7e49Rbm7kBLWDUEFdvBjE1tXtFnRAgmYsSk6Ws71W9sQFpZPK8SI5oiLTUJBvGvuYqNs7MDDMctNnZBQTC6aAu3scfH3ExO0tRImqhqXRnp7e3RTTnKB2EDqRa3M9AktLu9OTrq6uQizOIQKKY7kg6HKm2dklzM8vIfRmMiTJBQj0TfjZEURjhHYUdFKaFoaorW1mq0v8/cUQCtMhEGQhOlqGysomtqzLkPkNOUHtIDS45kWloLS0Tn/GsCjlGgQFJG0Z5CclFZCbLgeSlFxotd36s6bP/PwisVS9KCTxolyuIi5iCpyd+Ygj7mJebjmrtkKzNq2t7UzNYU5QOwxdN2dnF0a+yCb9GcPB52ezleZbQXtvhaIc2dkVSEz8+WLSpsr9+/dZrNXZ0Yd8pQYBAaksaU5f386kQuMEZQDa23thbR0MqdSwa9gyM4tQV6fVHz1MdXUzSkqqkZVVAV/fFP3ZXwY0HtupuJYTlIGgZUt9feOJC5jOcvUZArqxsaamTX/0MNnZZUhLK0Fhfi2E/Bz9WY7twgnKgFD3IyO1GB5uApRXNLLkLDtJUlIhvDxEJHh/fFAkLDgVufIqCAVStDYad3JNU4IT1C4gSSnER+9dhqsLH4KYLNTWNpFYawQjIzMYH19vY2MzbBU6rRFFhUdHtGggfe/ePTbC9aykSfLh4RELH694JIhyIBRK4WTPg71NGOKEWbgZlKC/kuNlwAnKwFRWtMD6eigLkunsf1VVC4mtChAaKoGlZQRbq0cb3cbu4hLLsrNSEfB4qcjIUEImyyOPeazgmlxRhmypGmmpJZBISpCaqvqp0ePMzFKWL4/HS8cNp2CcP+OOzz93xJfHXODmEsfWzwURQbW37+1Nf4aEE5SBcXaKRlPjs2WGpfMnCwvLbB5renoW/f1DbHKTDnJoNE1EjM0oL21AMnHthMJcxMU9aEKhksRIKlZ8ratrgFi9SbTrelmqMloJsbi4igivAAJ+Bq4TgbdtM9cFxzqcoAwI3VzH56eyiVVD0tk1hGieFOFBKRDypURMFaira0FjQwe83GPZhKi7O9/gf9dehBOUAWlt7SSuWA6LgwwFTQdtZRWMwoK6LTPSVte04ebNeOJu+pPrAtm+Ko4XhxOUAaHuV1pagf7IMNBK8XL5k+e/ZmZmSUwmJy0XSUk58PFJQHhYMrqJVeN4fjhBGRANEVRGRpH+yDCUl1dDrdLojx5nYmIKWVl0F68a+fnrGyFLimtwwymSZV3aasMix5PhBGVA6mu1SJXk6o8MQ11dG8vp9yRo7r6sLCXS0/OZqDagO2nT0orh7MhHUmKeQReYmjKcoAzI9NQsAv3jMDU5oz+z8wwPz+D8eX82t7UVHR0DEAozIZPlo6Xl8dFHOgfW1NS1Y4tJ9xqcoAwMzZPn7RVDLIDhilTn51fAxiaEzV3RXbF0wpgWTKONTvxGR0lhZx+CzMxi/TM4XhROULuARFIEZ+dItmXdUPT2jhIXLh/x8TJEhKbBwSEGTk5C4tJFsnzoocHJ5Ocolk2W48XhBLVL0AT69sQqZGWVsGF0WlCAJnWhVoPGL4tLK8yS0GHvB20cY2OzbKL3zupddv3PLUOi6wc33DW6FX9kZAqdnX0oLa2Bn18SfHyEyExft0wD/aNEaLuz1WSvwAlqF6Gb4cRiBT7/3BpeXgKWzzwyMg22tlG4Yh5GLIYAwpgsYlWyIRLJkJhI8yuIYGkRjvCQFMTFypAuyYVCWYSc7ALkKsugVtcjN7cKAkE2q0GVlJRNfk6HmVkgTp/2wxdf2JP3SIJKpUFZWQtbBb+Z7u4RtiHy3j0TTj20i3CC2kVGhqdZXgc691Nfr2XpxtbjmzVmsZ5kfajFmZ1dxOTkLBFAPzo6e6DTdqOijOZbKMKxY7aws4tGUVEtenoGMT4+BUvLYDQ2diHQPwFVmherlMjx83CC2iVmphbgZBuO4oKtd9S+KFptP7Nij+LkFEPiozYIohVQyl/ue3I8gBPULsGPyoRMqtIfvTzGRqfh7RGDvv5h/Zl1IiMzIJeXI8BPjNqaZ1ucy/H8cILaBWbn5omlSGXZYHeCbFkZ3NyikJmezwoDyDKL4ULisRhBFo4etiAuIrddY6fgBLUL0NIzKZLsHZ2LmpmZR2tzF5pbOlFT1YKCPA18PIX47jt3qFTcKN5OwQlqF1hbW0NgoJglZtxpmuo7EBqcAjcXPptjsrcXsHTNHDsDJ6hdglZvp3m8Xwa3V1dZwkdt2wAaG9pRVFgBYYwMtnaR8PcVsS33HR39LKuqjU0UlMpq/TM5XjacoHaJu3fvwc2Vh7LSF3O/iotrERychvCwdIhiMhEclAjraxGIiJBAkpwHeXYZysoa0dk5iP7+MbZmb3R0khPUDsMJahcZGhiFvXU4KiqefV6IFgCglSlcXQUskeVnRx1ZtcPlxVuIi5XD3DwEnV3DLDtqV9cQExLNGUEbJ6idhxPULkPjKGfnaOKWFTCX7GlMTc0Rq5SMoKBktuxoamoeFy7cxPjEDCbG55Acn0MsVBoTUw9pG0LiBGU4OEEZAXSFRGZ6EZwc+AghgikpqmEVCWkJz81V2unCib6+BwtqOzuHcelSEKqqtLjhwIMgMg1nTnnB3iaSJW+h6YY3C2psbBJXr0ZALn+xioovyhpxb1tbepmbu9fhBGVELC+tQqftgTS9hAhLgjhRFuLi0tkav5CQdPj7pyA0lMRLwelITFSyTLTniYWSphYhjcRNk5MzsLEKguXFEJz53gvZ2aXMWm0Iii6uDQhIYgnzDUmlpgkhxKrS5VR7HU5QRgwtRzM6OoGenmHU1LRDrW5GaWkzW0JEi2HTtXoXiYWSEeumkKtZFXknmzAkCfLh7ZqI48fdodX2soEJKigqLokknwjLcLVsx0ZnYGYWQOK5Qf2ZvQ0nKBNmYGACly4HQ5pWBHm2ilkoR+swiHgKCMJl2LfvIhFdzU+u38DAOGJiskjMxkNhYSV0ui4MDk5gdnaZldukWz1eFnRhLy1C7ekqREPt1vnV9yKcoEyYri4SQ20IKkeNiYnpnwQVHSrFvjcuEEFV/yQoOijh6MhnrmNVVROysvJYxtpLl0LIYzJLcaZQFCNXqYEip5LEWlVsEvhJjf5eKi1lyV0KCmirYj/n5FCLWQirK/6wsAiAWtXIkm3eu8/FUBxGzIagZBnFUCrKmHvoRAQVFyUnFiob7x+wIJaoCr2bBGVtHUnO1etfYR06WEBHEHt6BlgCzAIiCqFAjvDwLERESJ/Y6O9TUgqIK1oLlWq90Sru9DV6evpZptu6Oh2i+XKIYqUIu5nM9ntpNPUsjzvdTLnX4ARlwjxNUCKeHMeO2DGrsTEwsZvD5vfW7mGIuJzV1W3IzMyDg4MA0VFpSE3JRy05t7LyYDTTlOEEZcI8KqgRIih7IxXUo9ABv8H+UUgzVYgTynAzQIxw4n5qypswOTGrv8r04ARlwmwlKFu9oOKIoI4YsaAeZYKIiBaHi4nOgodbDKIj0pCrqMDY2LT+CtOAE5QJs5cEtZlVEltRNzA1qQABvvFs4EStrsPw8JT+CuOFE5QJs1cFtZnFxVvo6OgDn58JT08heUxHQV41Foy0UggnKBPmRQR17VokG+42RehcGa1vlRAvh7+XCAJeOnMTH83ctJtwgjJhnkdQdD9UH3m0sY0i7pPp79hdXFhmueIjw9MRHCJGTIwUdTVatmh4N+EEZcI8j6A6Oweg0/Uj0C8B2pZu/SvsDeh2f5qPUCSUwts9FpLkXDQ0dLGlW4aGE5QJs5WgNobNtxQUcfsCfRPQ1ry3BLUZup4xX6mBl1c8s1wSSQEGBw1XkocTlAnzqKA2T+z+UgW1GbqoWJalhrdnLBFXIokjd76OMCcoE4YT1LNBM/E2NrajpaVLf2bn4ARlwmwWVK6yfF1QNuGcoHYRTlAmDBXUZSIoaTotFlC8LijHaMRHK5mojhzlBGVoOEGZMMxCXQpiGw29vePZaJe9fSQEETKkigpx+GMb5OdVstXmnKAMAycoE4YKiiZpoXNMtrYRSE9XQRAjxfFjDvjkoDU+/8QBDXXtbHcvJyjDwAnKhKGCOncugC0g7esbIKKKhLMTH9fMb+LwYXukJBf+tLmQE5Rh4ARlwmwIitbNXV5eIsKaQqWmBRVljcRqDbLYiYrpJ0HRid0AIqhWTlA7BScoE2azoObn5zEyMoGOzkE2/0IFtCGmhwQVSATVxglqp+AEZcLQvHxnzvizLEZUUMPD49Bq+x4S0qOCCmCC2n6Rgrt37+L27VW2vGe93WHHs7MLbLUC3VL/cFs/t7x0i1374Hmr7Hl37tzRv7JpwwnKhKGV3WnqZZr8cn5+gQhq8omComm86uvbEUQENTCwdRoxmrl2YGCIXN8NjaYRpep6JCcWIIqXjdgYBVIlBazkaFpaATmfjcxMJTleb/Tn1FQ54uKkEAqliI19vAmFWUhMkD30vPXnKiCRyNnrpqcXknOFSEnKQ4xAjmh+DnmekmVvqqhoQGVlM/lfaEq0AVbqdGGBZmwyntwUnKBMmMnJOfj6JKCpqZsIapkNTrS19T4mpnVBDaGKxFehN8WYmHywC7abuIipEiWcXYQIDk4iN7UcMlk+cnJUUMjLkZVRirR0NfJyq9HU0I7m5k40N3Win8Rn9Iam2Wg3Gp0HWyIWiK74pjf55kYTstDHqekZcu3EQ88bH59kVpa+dlNTB1paOtnK8ZxsDRFXKRFcGUvamZtbQf4uNTnOQ1aWkggtDcIYKbzc42BpGc6mDsRiOaREkEWF5Sgvr0NtrY4tlNXpBsh7TbEsvdS67hScoHYAmpNuo92+fZft19ncaGHq/v5hdHR0E1eMJqJcbx0dPaznpa4RLUq9tvb0PHkzU/O46SdGfUMn6alvYWJi5omConFVYWENi6Eo9D14vDS4OvGgyCnD2PgsS/t8757xp/r68cf7LIcgdR3p3zw/v0T+n3mWY7C3dxgtze2orm6EUlmGpKRcVnPY1TUeItF6ZfzUVAXLvHvzZjqSkwvZbuCRkZezG5gT1CZonaWlpWVWqnNocJy5RvX1naiq0rH84eXlTcTlaGVps3JzVSgsKoNcVox48kXRL4umTPb3T4KFRTiuXo1kvaatbfRPLhB1eWiju09TUuTkCy+CXF74U1Moikjvm8uuuXkzmeXLCwuTIEdaTHrcKmaJFhYe7FSlNxItY1Nb2465qWXMTS9B27a1y9ffP0p69VK4uApRXtYMN+co5mLtlWxDzwKtnr+wsMisYWtrN/Lyash3UEk+8wJy3Km/anvsWUFR60A/wNu377Dea2R4gtxY3eSm1IEmZVQoyslNm4aAAAm5gbNJT6ZEkjibuBhyJBE/n4ojPj4Hnp5i0sMlsOuyslTM5Sgo0BA3oo28lpa4KTp2sw6T16cCHBubYdu2N9ry8gpzdx5tT8rSSv9u6pLQ3ndu7haGyOs2NeiQIs5jWxIEAgn8/JJQWtqAmdkFiGJlKCQ3xszkPBbmb5H/8eHRPdpoKmbq7ohEudj/1mV4Eheps6NP/44cLxOTExT1z2kAPj46he7uQZbnu6S4AaqSOhK4VpJep4T0/jlsB6ejowDXrkUgPFwCMRGHjPREeXkqlk21hFyfl1eLYvJc6ibR1xolQf3s7DwRwhJLbE9vbmODZoeliSrj42UI8IvHt185wYMIZJbEBrdvrzGXh66coCKibt7gEB356yViUuDCWW9EhaXj7p3d3dW6lzEaQVHfnfbKS0srpDedJjf4AHG3Wog1qEBiQi7c3BIQFp6BhHhiTcRSJCdSCyInViYVocHpyJapmSvW1tbBnktLZNIAmQbC9LX3YuWHRRI3Zaap4HQjmnw+ccTqVqCmRoe6unbW8vKqEBqUTDoWHnx84qFr3fn9QL90DCYoKpaZmTkMEPeooZ582bk1JA6pRHZ2MWSyAuZieXsnsLgjPDwNEuKC5SpLUKKqZj4/rfKn0/Ux12qWBPUrt385vv/PQa02jfGSkhQsd/mlS8EwNw8ln2MqFPIyZqk4DMO2BbUx2rK4uIzx8Rn25dHYQq2uQmpqPhGJmAklNpYE4skypJAvPS4mB2GhGcjILEZZWT0RSheb5Z+bW/7ZkS0ODmPmuQVFA/CMDDVpKkilhUhLoxNvGcTlEMLWNgrR0ekkeM8nsUkFsSpNqK7WscCYBsU0Nllb4/x3jr3LcwmKxuiVlVpWfTwjo4SIhc5a97FAeWXF8BlmODiMDaMZlODg2AtwguLgeGkA/x85EDHfSxiuVgAAAABJRU5ErkJggg=="
          },
          {
            "resourceType" : "Binary",
            "id" : "image11",
            "contentType" : "image/png",
            "data" : "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"
          },
          {
            "resourceType" : "Binary",
            "id" : "image12",
            "contentType" : "image/png",
            "data" : "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"
          }
        ],
        "extension" : [
          {
            "url" : "http://hl7.org/fhir",
            "valueReference" : {
              "reference" : "#image1"
            }
          },
          {
            "url" : "http://hl7.org/fhir",
            "valueReference" : {
              "reference" : "#image2"
            }
          },
          {
            "url" : "http://hl7.org/fhir",
            "valueReference" : {
              "reference" : "#image3"
            }
          },
          {
            "url" : "http://hl7.org/fhir",
            "valueReference" : {
              "reference" : "#image4"
            }
          },
          {
            "url" : "http://hl7.org/fhir",
            "valueReference" : {
              "reference" : "#image5"
            }
          },
          {
            "url" : "http://hl7.org/fhir",
            "valueReference" : {
              "reference" : "#image7"
            }
          },
          {
            "url" : "http://hl7.org/fhir",
            "valueReference" : {
              "reference" : "#image8"
            }
          },
          {
            "url" : "http://hl7.org/fhir",
            "valueReference" : {
              "reference" : "#image9"
            }
          },
          {
            "url" : "http://hl7.org/fhir",
            "valueReference" : {
              "reference" : "#image10"
            }
          },
          {
            "url" : "http://hl7.org/fhir",
            "valueReference" : {
              "reference" : "#image11"
            }
          },
          {
            "url" : "http://hl7.org/fhir",
            "valueReference" : {
              "reference" : "#image12"
            }
          }
        ],
        "identifier" : [
          {
            "system" : "https://www.minzdrav.gov.ru/",
            "value" : "0d69fdcb-33cf-407f-8209-a6529856ab4f"
          }
        ],
        "status" : "final",
        "type" : {
          "coding" : [
            {
              "system" : "https://www.minzdrav.gov.ru/",
              "code" : "100000155538"
            }
          ],
          "text" : "Package Leaflet"
        },
        "subject" : [
          {
            "reference" : "MedicinalProductDefinition/mp50mg"
          }
        ],
        "date" : "2023-08-16T00:00:00Z",
        "author" : [
          {
            "reference" : "Organization/orgpfizerusinc"
          }
        ],
        "title" : "Enbrel® (etanercept) 50 mg/ml solution for subcutaneous injection",
        "section" : [
          {
            "title" : "MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"/>"
            },
            "section" : [
              {
                "title" : "INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT",
                "code" : {
                  "coding" : [
                    {
                      "system" : "https://www.minzdrav.gov.ru/",
                      "code" : "100000155538"
                    }
                  ],
                  "text" : "INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT"
                },
                "text" : {
                  "status" : "generated",
                  "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<b>Registration number:</b> LSR-006652/09\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<b>Invented name:</b> Enbrel<sup>®</sup>\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<b>International non-proprietary name:</b> etanercept\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<b>Pharmaceutical form:</b> solution for subcutaneous\n\t\t\t\t\t\t\t\t\tinjection\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<b>Composition</b>\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>Composition per 1 mL of solution </p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<b>active substance:</b>etanercept 50.0 mg;\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\texcipients: L-arginine hydrochloride 5.3 mg, sodium chloride 5.8 mg,\n\t\t\t\t\t\t\t\t\tsucrose 10.0 mg, sodium hydrogen phosphate dihydrate 1.2 mg, sodium\n\t\t\t\t\t\t\t\t\tdihydrogen phosphate dihydrate 2.9 mg, water for injection to 1.0\n\t\t\t\t\t\t\t\t\tmL.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<b>Description</b>\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tClear or opalescent from colorless to yellow or light brown liquid.\n\t\t\t\t\t\t\t\t\tSmall transparent to white amorphous particles are permissible.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<b>Pharmacotherapeutic group:</b> tumor necrosis factor-α (TNF-α) inhibitor\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<b>ATC Code:</b> L04AB01\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t</div>"
                }
              },
              {
                "title" : "Pharmacological properties",
                "code" : {
                  "coding" : [
                    {
                      "system" : "https://www.minzdrav.gov.ru/",
                      "code" : "100000155538"
                    }
                  ],
                  "text" : "Pharmacological properties"
                },
                "text" : {
                  "status" : "generated",
                  "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"/>"
                },
                "section" : [
                  {
                    "title" : "Pharmacodynamics",
                    "code" : {
                      "coding" : [
                        {
                          "system" : "https://www.minzdrav.gov.ru/",
                          "code" : "100000155538"
                        }
                      ],
                      "text" : "Pharmacodynamics"
                    },
                    "text" : {
                      "status" : "generated",
                      "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tTumor necrosis factor (TNF-α) is the main cytokine maintaining the\n\t\t\t\t\t\t\t\t\t\tinflammatory process in rheumatoid arthritis. An increase in the\n\t\t\t\t\t\t\t\t\t\tconcentration of TNF has also been found in synovial membranes and\n\t\t\t\t\t\t\t\t\t\tpsoriatic plaques in psoriatic arthritis patients, as well as in blood\n\t\t\t\t\t\t\t\t\t\tplasma and synovial tissues in ankylosing spondylitis patients.\n\t\t\t\t\t\t\t\t\t\tEtanercept is a competitive inhibitor of the binding of TNF to its\n\t\t\t\t\t\t\t\t\t\treceptors on the cell surface and thereby inhibits the biological\n\t\t\t\t\t\t\t\t\t\tactivity of TNF. TNF and lymphotoxin are pro-inflammatory cytokines that\n\t\t\t\t\t\t\t\t\t\tbind to two different tumor necrosis factor receptors (TNFRs) on the\n\t\t\t\t\t\t\t\t\t\tcell surface: 55 kilodalton (р55) and 75 kilodalton (р75). Both TNFRs\n\t\t\t\t\t\t\t\t\t\tare present in the body in membrane-bound and free forms. Soluble TNFRs\n\t\t\t\t\t\t\t\t\t\tregulate the biological activity of TNF.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tTNF and lymphotoxin exist predominantly as homotrimers, with their\n\t\t\t\t\t\t\t\t\t\tbiological activity dependent on the cross-linking of TNFRs that are\n\t\t\t\t\t\t\t\t\t\tsituated on the cell surface. Dimeric soluble receptors, such as\n\t\t\t\t\t\t\t\t\t\tetanercept, possess higher TNF binding affinity than monomeric receptors\n\t\t\t\t\t\t\t\t\t\tand, therefore, are significantly more potent competitive inhibitors of\n\t\t\t\t\t\t\t\t\t\tTNF binding to its cellular receptors. Moreover, the use of an\n\t\t\t\t\t\t\t\t\t\timmunoglobulin Fc region as a fusion element in the structure of a\n\t\t\t\t\t\t\t\t\t\tdimeric receptor prolongs the blood serum half-life period.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThe significant portion of pathological processes in joints in\n\t\t\t\t\t\t\t\t\t\trheumatoid arthritis and ankylosing spondylitis, and also skin\n\t\t\t\t\t\t\t\t\t\tpathologies presenting as plaque psoriasis, develop due to the effect of\n\t\t\t\t\t\t\t\t\t\tpro-inflammatory molecules involved in a network controlled by TNF. The\n\t\t\t\t\t\t\t\t\t\tmechanism of action of etanercept is thought to be its competitive\n\t\t\t\t\t\t\t\t\t\tinhibition of TNF binding to TNF receptors on the cell surface. Thus,\n\t\t\t\t\t\t\t\t\t\tetanercept prevents TNF-mediated cellular responses by rendering TNF\n\t\t\t\t\t\t\t\t\t\tbiologically inactive. Etanercept can also modulate biological responses\n\t\t\t\t\t\t\t\t\t\tcontrolled by additional downstream molecules (e.g., cytokines, adhesion\n\t\t\t\t\t\t\t\t\t\tmolecules or proteinases). And these responses may either induce or\n\t\t\t\t\t\t\t\t\t\tcontrol TNF.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIn patients with active psoriatic arthritis, Enbrel<sup>\n\t\t\t\t\t\t\t\t\t\t\t<sup>®</sup>\n\t\t\t\t\t\t\t\t\t\t</sup> inhibits the\n\t\t\t\t\t\t\t\t\t\tprogression of structural damage, improves physical activity and lowers\n\t\t\t\t\t\t\t\t\t\tthe likelihood of development of lesions in the peripheral joints.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tAfter discontinuing treatment with Enbrel<sup>\n\t\t\t\t\t\t\t\t\t\t\t<sup>®</sup>\n\t\t\t\t\t\t\t\t\t\t</sup>, the flare-up of the\n\t\t\t\t\t\t\t\t\t\tdisease is possible within a month. The efficacy of the repeated\n\t\t\t\t\t\t\t\t\t\tadministration of the medicinal product within 24 months after\n\t\t\t\t\t\t\t\t\t\tdiscontinuing the therapy is comparable to that in patients who have not\n\t\t\t\t\t\t\t\t\t\tinterrupted the treatment.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</div>"
                    }
                  },
                  {
                    "title" : "Pharmacokinetics",
                    "code" : {
                      "coding" : [
                        {
                          "system" : "https://www.minzdrav.gov.ru/",
                          "code" : "100000155538"
                        }
                      ],
                      "text" : "Pharmacokinetics"
                    },
                    "text" : {
                      "status" : "generated",
                      "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tEtanercept is slowly absorbed from the site of subcutaneous\n\t\t\t\t\t\t\t\t\t\tinjection, reaching its maximum concentration in approximately 48 hours\n\t\t\t\t\t\t\t\t\t\tafter the administration of a single dose of Enbrel<sup>®</sup>. The absolute\n\t\t\t\t\t\t\t\t\t\tbioavailability is 76%. When Enbrel<sup>®</sup> is administered twice a week,\n\t\t\t\t\t\t\t\t\t\tsteady-state concentrations twice as high as those observed after a\n\t\t\t\t\t\t\t\t\t\tsingle administration are achieved. After the single subcutaneous\n\t\t\t\t\t\t\t\t\t\tadministration of Enbrel<sup>®</sup> 25 mg, the mean maximum plasma concentration\n\t\t\t\t\t\t\t\t\t\tof etanercept was 1.65 ± 0.66 µg/mL, and the area under the\n\t\t\t\t\t\t\t\t\t\tconcentration-time curve (AUC) was 235 ± 96.6 µg⋅h/mL. There was no\n\t\t\t\t\t\t\t\t\t\tapparent saturation of clearance across the dosing range.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThe dependence of the concentration of etanercept on time is\n\t\t\t\t\t\t\t\t\t\trepresented by a biexponential curve. The mean volume of distribution is\n\t\t\t\t\t\t\t\t\t\t7.6 L, whereas the steady-state volume of distribution is\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>10.4 L.</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tEtanercept is cleared slowly from the body. The half-life (Т1/2) is\n\t\t\t\t\t\t\t\t\t\tabout 70 hours. For patients with rheumatoid arthritis, the clearance is\n\t\t\t\t\t\t\t\t\t\tapproximately 0.066 L/h, which is somewhat lower than a value of 0.11\n\t\t\t\t\t\t\t\t\t\tL/h for healthy volunteers. The pharmacokinetic properties of etanercept\n\t\t\t\t\t\t\t\t\t\tin patients with rheumatoid arthritis, ankylosing spondylarthritis and\n\t\t\t\t\t\t\t\t\t\tpsoriasis are similar.\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tA single 50 mg dose of Enbrel<sup>®</sup> is bioequivalent to a dose consisting\n\t\t\t\t\t\t\t\t\t\tof two practically simultaneous injections of 25 mg of the medicinal\n\t\t\t\t\t\t\t\t\t\tproduct. Although there is elimination of radioactivity through the\n\t\t\t\t\t\t\t\t\t\tkidneys after the administration of radiolabeled etanercept to patients\n\t\t\t\t\t\t\t\t\t\tand healthy volunteers, no increase in the blood plasma concentrations\n\t\t\t\t\t\t\t\t\t\tof etanercept was observed in patients with acute renal or hepatic\n\t\t\t\t\t\t\t\t\t\tfailure. In patients with acute renal or hepatic failure, no increase in\n\t\t\t\t\t\t\t\t\t\tthe concentration of etanercept was observed.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThere are no significant differences in the pharmacokinetics of\n\t\t\t\t\t\t\t\t\t\tetanercept among men and women.\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>Elderly patients</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThe clearance and apparent volumes of distribution of etanercept in\n\t\t\t\t\t\t\t\t\t\tthe group of patients aged from 65 to 87 years are similar to those in\n\t\t\t\t\t\t\t\t\t\tpatients under 65.\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>Children</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<u>Juvenile idiopathic polyarthritis</u>\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThe blood serum concentration profile is similar to that of adult\n\t\t\t\t\t\t\t\t\t\tpatients with rheumatoid arthritis. Simulation suggests that while older\n\t\t\t\t\t\t\t\t\t\tchildren (aged 10 to 17 years) and adults have roughly the same blood\n\t\t\t\t\t\t\t\t\t\tserum concentrations of etanercept, younger children will have\n\t\t\t\t\t\t\t\t\t\tappreciably lower levels.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<u>Psoriasis</u>\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThe steady-state concentrations of etanercept in the blood plasma of\n\t\t\t\t\t\t\t\t\t\tchildren aged from 4 to 17 years with psoriasis and children with\n\t\t\t\t\t\t\t\t\t\tjuvenile idiopathic polyarthritis who had received Enbrel<sup>®</sup> at doses of\n\t\t\t\t\t\t\t\t\t\t0.8 mg/kg once a week (the maximum dose of 50 mg per week) and 0.4 mg/kg\n\t\t\t\t\t\t\t\t\t\ttwice a week (the maximum dose of 50 mg per week) over the course of 48\n\t\t\t\t\t\t\t\t\t\tand 12 weeks were similar (1.6 to 2.1 μg/mL). The value of this metric\n\t\t\t\t\t\t\t\t\t\tcoincided with that of adult patients with psoriasis administered\n\t\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> at a dose of 25 mg twice a week.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</div>"
                    }
                  }
                ]
              }
            ]
          },
          {
            "title" : "Indications for use",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Indications for use"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Rheumatoid arthritis</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tIn combination with methotrexate, Enbrel<sup>®</sup> is prescribed to adults for\n\t\t\t\t\t\t\t\tthe treatment of moderate and severe active rheumatoid arthritis when\n\t\t\t\t\t\t\t\tresponse to disease-modifying anti-rheumatic drugs (DMARDs), including\n\t\t\t\t\t\t\t\tmethotrexate, has been inadequate.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> may be prescribed as monotherapy in case of inefficacy or\n\t\t\t\t\t\t\t\tintolerance of methotrexate. Enbrel<sup>®</sup> is indicated for the treatment of\n\t\t\t\t\t\t\t\tsevere active and progressive rheumatoid arthritis in adults who have\n\t\t\t\t\t\t\t\tnot been previously treated with methotrexate.\n\t\t\t\t\t\t\t</p>\n\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Juvenile idiopathic polyarthritis</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tTreatment of active juvenile idiopathic polyarthritis (seropositive\n\t\t\t\t\t\t\t\tand seronegative) in children and adolescents aged 12 years and older\n\t\t\t\t\t\t\t\twith a body weight of more than 62.5 kg (for Enbrel<sup>®</sup> in the\n\t\t\t\t\t\t\t\tpharmaceutical form of a solution for subcutaneous injection), who have\n\t\t\t\t\t\t\t\thad an ineffective response or intolerance to methotrexate.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tTreatment of extended oligoarthritis in children and adolescents aged\n\t\t\t\t\t\t\t\t12 years and older with a body weight of more than 62.5 kg (for Enbrel<sup>®</sup>\n\t\t\t\t\t\t\t\tin the pharmaceutical form of a “solution for subcutaneous injection”),\n\t\t\t\t\t\t\t\twho have had an ineffective response or intolerance to methotrexate.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tTreatment of psoriatic arthritis in adolescents aged 12 years and\n\t\t\t\t\t\t\t\tolder with a body weight of more than 62.5 kg (for Enbrel<sup>®</sup> in the\n\t\t\t\t\t\t\t\tpharmaceutical form of a “solution for subcutaneous injection”), who\n\t\t\t\t\t\t\t\thave had an ineffective response or intolerance to methotrexate.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tTreatment of arthritis associated with enthesitis in adolescents aged\n\t\t\t\t\t\t\t\t12 years and older with a body weight of more than 62.5 kg (for Enbrel<sup>®</sup>\n\t\t\t\t\t\t\t\tin the pharmaceutical form of a “solution for subcutaneous injection”),\n\t\t\t\t\t\t\t\twho have had an ineffective response or intolerance to standard\n\t\t\t\t\t\t\t\ttherapy.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Psoriatic arthritis</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tTreatment of active and progressive psoriatic arthritis in adults who\n\t\t\t\t\t\t\t\thave had an inadequate response to DMARDs.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Axial spondylarthritis</em>\n\t\t\t\t\t\t\t\t<em>Ankylosing spondylitis</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tTreatment of severe active ankylosing spondylitis in adults for whom\n\t\t\t\t\t\t\t\tconventional therapy has not resulted in substantial improvement.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Non-radiographic of axial spondylarthritis</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tEtanercept is indicated for treatment of adult patients with severe\n\t\t\t\t\t\t\t\tcourse of axial spondylarthritis in the non-radiographic stage, in whom\n\t\t\t\t\t\t\t\tan inadequate response or resistance to standard treatment has been\n\t\t\t\t\t\t\t\tobserved and who also have objective signs of active disease confirmed\n\t\t\t\t\t\t\t\tby an increased concentration of C-reactive protein (CRP) and/or MRI\n\t\t\t\t\t\t\t\tscan data.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Psoriasis</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tTreatment of adults with moderate and severe psoriasis, who have\n\t\t\t\t\t\t\t\tcontraindications or intolerance to other systemic treatments, including\n\t\t\t\t\t\t\t\tcyclosporine, methotrexate or PUVA therapy.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tTreatment of children aged 12 years and older with a body weight of\n\t\t\t\t\t\t\t\tmore than 62.5 kg (for Enbrel<sup>®</sup> in the pharmaceutical form of a “solution\n\t\t\t\t\t\t\t\tfor subcutaneous injection”) with severe chronic psoriasis, who have had\n\t\t\t\t\t\t\t\tan intolerance or inadequate response to other systemic therapy or\n\t\t\t\t\t\t\t\tphototherapy.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t</div>"
            }
          },
          {
            "title" : "Contraindications",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Contraindications"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tHypersensitivity to etanercept or any other component of the\n\t\t\t\t\t\t\t\tmedication. Sepsis or risk of sepsis.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>Active infection, including chronic or localized infections.</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tPatients aged under 12 years with a body weight of less than 62.5 kg\n\t\t\t\t\t\t\t\t(for Enbrel<sup>®</sup> in the pharmaceutical form of a “solution for subcutaneous\n\t\t\t\t\t\t\t\tinjection”).\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t</div>"
            }
          },
          {
            "title" : "Precautions",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Precautions"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tDemyelinating diseases, chronic heart failure (CHF), immunodeficiency\n\t\t\t\t\t\t\t\tconditions, diseases that cause predisposition to the development or\n\t\t\t\t\t\t\t\tactivation of infections (diabetes, hepatitis), moderate and severe\n\t\t\t\t\t\t\t\talcoholic hepatitis, hepatitis C, blood dyscrasia, diseases of the\n\t\t\t\t\t\t\t\tnervous system (multiple sclerosis, optic neuritis, transverse\n\t\t\t\t\t\t\t\tmyelitis).\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t</div>"
            }
          },
          {
            "title" : "Use during pregnancy and breast-feeding period",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Use during pregnancy and breast-feeding period"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"/>"
            },
            "section" : [
              {
                "title" : "Women of childbearing potential",
                "code" : {
                  "coding" : [
                    {
                      "system" : "https://www.minzdrav.gov.ru/",
                      "code" : "100000155538"
                    }
                  ],
                  "text" : "Women of childbearing potential"
                },
                "text" : {
                  "status" : "generated",
                  "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tWomen of childbearing potential should consider the use of\n\t\t\t\t\t\t\t\t\tappropriate contraception to avoid becoming pregnant during therapy with\n\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> and for three weeks after the discontinuation of the\n\t\t\t\t\t\t\t\t\ttherapy.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t</div>"
                }
              },
              {
                "title" : "Pregnancy",
                "code" : {
                  "coding" : [
                    {
                      "system" : "https://www.minzdrav.gov.ru/",
                      "code" : "100000155538"
                    }
                  ],
                  "text" : "Pregnancy"
                },
                "text" : {
                  "status" : "generated",
                  "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tThe effects of etanercept on pregnancy outcomes have been\n\t\t\t\t\t\t\t\t\tinvestigated in two observational cohort studies. A higher rate of major\n\t\t\t\t\t\t\t\t\tbirth defects was observed in one observational study comparing\n\t\t\t\t\t\t\t\t\tpregnancies exposed to etanercept during the first trimester, with\n\t\t\t\t\t\t\t\t\tpregnancies not exposed to etanercept or other TNF-antagonists. The\n\t\t\t\t\t\t\t\t\ttypes of major birth defects were consistent with those most commonly\n\t\t\t\t\t\t\t\t\treported in the general population and no particular pattern of\n\t\t\t\t\t\t\t\t\tabnormalities was identified. No change in the rate of spontaneous\n\t\t\t\t\t\t\t\t\tabortion, stillbirth, or minor malformations was observed. In another\n\t\t\t\t\t\t\t\t\tobservational multi-country registry study comparing the risk of adverse\n\t\t\t\t\t\t\t\t\tpregnancy outcomes in women exposed to etanercept during the first 90\n\t\t\t\t\t\t\t\t\tdays of pregnancy to those exposed to non-biologic medications, there\n\t\t\t\t\t\t\t\t\twas no observed increased risk of major birth defects. That study also\n\t\t\t\t\t\t\t\t\tshowed no increased risks of minor birth defects, preterm birth,\n\t\t\t\t\t\t\t\t\tstillbirth, or infections in the first year of life for infants born to\n\t\t\t\t\t\t\t\t\twomen exposed to etanercept during pregnancy. Enbrel<sup>®</sup> should only be\n\t\t\t\t\t\t\t\t\tused during pregnancy if clearly needed.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tEtanercept penetrates the placenta and is detected in the serum of\n\t\t\t\t\t\t\t\t\tinfants born to female patients treated with Enbrel<sup>®</sup> during pregnancy.\n\t\t\t\t\t\t\t\t\tThe clinical impact of this is unknown, however, infants\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tmay be at increased risk of infection. The administration of live\n\t\t\t\t\t\t\t\t\tvaccines to infants for 16 weeks after the mother’s last dose of\n\t\t\t\t\t\t\t\t\tetanercept is generally not recommended.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t</div>"
                }
              },
              {
                "title" : "Breast-feeding",
                "code" : {
                  "coding" : [
                    {
                      "system" : "https://www.minzdrav.gov.ru/",
                      "code" : "100000155538"
                    }
                  ],
                  "text" : "Breast-feeding"
                },
                "text" : {
                  "status" : "generated",
                  "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tLimited information from the published literature indicates that\n\t\t\t\t\t\t\t\t\tetanercept has been detected at low levels in human milk. Etanercept\n\t\t\t\t\t\t\t\t\tcould be considered for use during breast-feeding taking into account\n\t\t\t\t\t\t\t\t\tthe benefit of breast-feeding for the child and the benefit of therapy\n\t\t\t\t\t\t\t\t\tfor the woman. Although systemic exposure in a breastfed infant is\n\t\t\t\t\t\t\t\t\texpected to be low because etanercept is largely degraded in the\n\t\t\t\t\t\t\t\t\tgastrointestinal tract, limited data regarding systemic exposure in the\n\t\t\t\t\t\t\t\t\tbreastfed infant are available. Therefore, the administration of live\n\t\t\t\t\t\t\t\t\tvaccines (eg, BCG) to a breastfed infant when the mother is receiving\n\t\t\t\t\t\t\t\t\tetanercept may be considered 16 weeks after stopping breast-feeding (or\n\t\t\t\t\t\t\t\t\tat an earlier timepoint if the infant’s etanercept serum levels are\n\t\t\t\t\t\t\t\t\tundetectable).\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t</div>"
                }
              },
              {
                "title" : "Reproductive function",
                "code" : {
                  "coding" : [
                    {
                      "system" : "https://www.minzdrav.gov.ru/",
                      "code" : "100000155538"
                    }
                  ],
                  "text" : "Reproductive function"
                },
                "text" : {
                  "status" : "generated",
                  "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tPreclinical data on the peri- and postnatal toxicity of etanercept\n\t\t\t\t\t\t\t\t\tand of effects of etanercept on fertility and overall reproductive\n\t\t\t\t\t\t\t\t\tperformance are not available.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t</div>"
                }
              }
            ]
          },
          {
            "title" : "Posology and method of administration",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Posology and method of administration"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t<p>Subcutaneously.</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tTreatment with Enbrel<sup>®</sup> must be prescribed and monitored by a\n\t\t\t\t\t\t\t\tphysician experienced in the diagnosis and treatment of rheumatoid\n\t\t\t\t\t\t\t\tarthritis, juvenile idiopathic polyarthritis, psoriatic arthritis,\n\t\t\t\t\t\t\t\tankylosing spondylitis or psoriasis.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> in the form of a 25 mg ready-for-use solution (a single-use\n\t\t\t\t\t\t\t\tsyringe containing 0.5 mL of the medicinal product) and 50 mg (a\n\t\t\t\t\t\t\t\tsingle-use syringe containing 1.0 mL of the medicinal product) or 50 mg\n\t\t\t\t\t\t\t\t(injection pen containing 1 mL of the medicinal product) is used for\n\t\t\t\t\t\t\t\tpatients with a body weight of <b>more than 62.5 kg</b>. For\n\t\t\t\t\t\t\t\tpatients with a body weight of less than 62.5 kg, lyophilizate for the\n\t\t\t\t\t\t\t\tpreparation of a solution should be used.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\tbefore-injecting-the-medicinal-product-it-is-necessary-to-read-the-instructions-for-use-at-the-end-of-this-section-carefully. Before\n\t\t\t\t\t\t\t\tinjecting the medicinal product, it is necessary to read the\n\t\t\t\t\t\t\t\tinstructions for use at the end of this section carefully.\n\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t</div>"
            }
          },
          {
            "title" : "Adults",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Adults"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Rheumatoid arthritis</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tThe recommended dose is 25 mg of Enbrel<sup>®</sup> twice a week with an\n\t\t\t\t\t\t\t\tinterval of three to four days. An alternative dose is 50 mg once a\n\t\t\t\t\t\t\t\tweek, which can be administered as a single subcutaneous injection of 50\n\t\t\t\t\t\t\t\tmg or two practically simultaneous injections of 25 mg.\n\t\t\t\t\t\t\t</p>\n\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Psoriatic arthritis</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tThe recommended dose is 25 mg of Enbrel<sup>®</sup> twice a week with an\n\t\t\t\t\t\t\t\tinterval of three to four days. An alternative dose is 50 mg once a\n\t\t\t\t\t\t\t\tweek, which can be administered as a single subcutaneous injection of 50\n\t\t\t\t\t\t\t\tmg or two practically simultaneous injections of 25 mg.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Ankylosing spondylitis</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tThe recommended dose is 25 mg of Enbrel<sup>®</sup> twice a week with an\n\t\t\t\t\t\t\t\tinterval of three to four days. An alternative dose is 50 mg once a\n\t\t\t\t\t\t\t\tweek, which can be administered as a single subcutaneous injection of 50\n\t\t\t\t\t\t\t\tmg or two practically simultaneous injections of 25 mg.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Pre-radiographic axial spondylarthritis</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tThe recommended dose is 25 mg of Enbrel<sup>®</sup> twice a week with an\n\t\t\t\t\t\t\t\tinterval of three to four days. An alternative dose is 50 mg once a\n\t\t\t\t\t\t\t\tweek, which can be administered as a single subcutaneous injection of 50\n\t\t\t\t\t\t\t\tmg or two practically simultaneous injections of 25 mg.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Psoriasis</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tThe recommended dose is 25 mg of Enbrel<sup>®</sup> twice a week with an\n\t\t\t\t\t\t\t\tinterval of three to four days. It is possible to administer 50 mg of\n\t\t\t\t\t\t\t\tthe medicinal product once a week as a single subcutaneous injection or\n\t\t\t\t\t\t\t\ttwo practically simultaneous injections of 25 mg.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tAs an alternative, 50 mg of Enbrel<sup>®</sup> can be used twice a week for a\n\t\t\t\t\t\t\t\tperiod of not more than 12 weeks. If treatment needs to be continued,\n\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> should be administered at a dose of 25 mg twice a week or 50 mg\n\t\t\t\t\t\t\t\tonce a week. Treatment should be continued until remission is reached\n\t\t\t\t\t\t\t\tand, as a rule, for not more than 24 weeks. The administration of the\n\t\t\t\t\t\t\t\tmedicinal product should be discontinued if, after 12 weeks of\n\t\t\t\t\t\t\t\ttreatment, no improvement in symptoms is observed. In some cases, the\n\t\t\t\t\t\t\t\tlength of treatment may be more than 24 weeks.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tIn adult patients, depending on the physician’s evaluation and\n\t\t\t\t\t\t\t\tindividual peculiarities of the patient, therapy can be either\n\t\t\t\t\t\t\t\tcontinuous or intermittent.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tIf repeated administration of Enbrel<sup>®</sup> is needed, the duration of\n\t\t\t\t\t\t\t\ttreatment stated above should be observed. It is recommended to\n\t\t\t\t\t\t\t\tprescribe a dose of 25 mg twice a week or 50 mg once a week.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>The duration of treatment for some patients may exceed 24 weeks.</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Elderly patients (65 years and older)</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>There is no need to adjust the dose or method of administration.</p>\n\t\t\t\t\t\t</div>"
            }
          },
          {
            "title" : "Children (aged 12 years and older with a body weight of 62.5 kg and more)",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Children (aged 12 years and older with a body weight of 62.5 kg and more)"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tIn children aged under 12 years with a body weight of less than 62.5\n\t\t\t\t\t\t\t\tkg (see “Contraindications” section), Enbrel<sup>®</sup> in the pharmaceutical form\n\t\t\t\t\t\t\t\tof a lyophilizate for solution for subcutaneous injection should be\n\t\t\t\t\t\t\t\tused, making it possible to administer a dose of less than 25 mg.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tChildren aged 12 years and older with a body weight of more than 62.5\n\t\t\t\t\t\t\t\tkg can be administered Enbrel<sup>®</sup> in the pharmaceutical form of a solution\n\t\t\t\t\t\t\t\tfor subcutaneous injection in single-use syringes or injection pens.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\tJuvenile idiopathic polyarthritis (children aged 12 years and\n\t\t\t\t\t\t\t\t\tolder with a body weight of more than 62.5 kg [for Enbrel\n\t\t\t\t\t\t\t\t</em><sup>®</sup> <em>\n\t\t\t\t\t\t\t\t\tin\n\t\t\t\t\t\t\t\t\tthe pharmaceutical form of a “solution for subcutaneous\n\t\t\t\t\t\t\t\t\tinjection”])\n\t\t\t\t\t\t\t\t</em> Enbrel<sup>®</sup> in the pharmaceutical form of a “solution for\n\t\t\t\t\t\t\t\tsubcutaneous injection” is administered in this patient group in the\n\t\t\t\t\t\t\t\tsame way as in adult patients: a single 25 mg dose. The medicinal\n\t\t\t\t\t\t\t\tproduct is injected twice a week with an interval of three to four days.\n\t\t\t\t\t\t\t\tTreatment should be discontinued if, after four months of therapy, no\n\t\t\t\t\t\t\t\timprovement in symptoms is observed.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>The administration of a 50 mg dose once per week is possible.</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\tExtended oligoarthritis (children aged 12 years and older with a\n\t\t\t\t\t\t\t\t\tbody weight of more than 62.5 kg [for Enbrel\n\t\t\t\t\t\t\t\t</em>\n\t\t\t\t\t\t\t\t<sup>®</sup>\n\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\tin the\n\t\t\t\t\t\t\t\t\tpharmaceutical form of a “solution for subcutaneous\n\t\t\t\t\t\t\t\t\tinjection”])\n\t\t\t\t\t\t\t\t</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> in the pharmaceutical form of a “solution for subcutaneous\n\t\t\t\t\t\t\t\tinjection” is administered in this patient group in the same way as in\n\t\t\t\t\t\t\t\tadult patients: a single 25 mg dose. The medicinal product is injected\n\t\t\t\t\t\t\t\ttwice a week with an interval of three to four days. Treatment should be\n\t\t\t\t\t\t\t\tdiscontinued if, after four months of therapy, no improvement in\n\t\t\t\t\t\t\t\tsymptoms is observed.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>The administration of a 50 mg dose once per week is possible.</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\tPsoriatic arthritis (adolescents aged 12 years and older, and\n\t\t\t\t\t\t\t\t\twith a body weight greater than 62.5 kg [for Enbrel\n\t\t\t\t\t\t\t\t</em>\n\t\t\t\t\t\t\t\t<sup>®</sup>\n\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\tin the\n\t\t\t\t\t\t\t\t\tpharmaceutical form of a “solution for subcutaneous\n\t\t\t\t\t\t\t\t\tinjection”])\n\t\t\t\t\t\t\t\t</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> in the pharmaceutical form of a “solution for subcutaneous\n\t\t\t\t\t\t\t\tinjection” is administered in this patient group in the same way as in\n\t\t\t\t\t\t\t\tadult patients: a single 25 mg dose. The medicinal product is injected\n\t\t\t\t\t\t\t\ttwice a week with an interval of three to four days. Treatment should be\n\t\t\t\t\t\t\t\tdiscontinued if, after four months of therapy, no improvement in\n\t\t\t\t\t\t\t\tsymptoms is observed.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>The administration of a 50 mg dose once per week is possible.</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\tArthritis associated with enthesitis (adolescents aged 12 years\n\t\t\t\t\t\t\t\t\tand older with a body weight of more than 62.5 kg [for Enbrel\n\t\t\t\t\t\t\t\t</em>\n\t\t\t\t\t\t\t\t<sup>®</sup>\n\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\tin the pharmaceutical form of a “solution for subcutaneous\n\t\t\t\t\t\t\t\t\tinjection”])\n\t\t\t\t\t\t\t\t</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> in the pharmaceutical form of a “solution for subcutaneous\n\t\t\t\t\t\t\t\tinjection” is administered in this patient group in the same way as in\n\t\t\t\t\t\t\t\tadult patients: a single 25 mg dose. The medicinal product\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tis injected twice a week with an interval of three to four days.\n\t\t\t\t\t\t\t\tTreatment should be discontinued if, after four months of therapy, no\n\t\t\t\t\t\t\t\timprovement in symptoms is observed.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>The administration of a 50 mg dose once per week is possible.</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\tPsoriasis (children aged 12 years and older with a body weight of\n\t\t\t\t\t\t\t\t\tmore than 62.5 kg [for Enbrel\n\t\t\t\t\t\t\t\t</em>\n\t\t\t\t\t\t\t\t<sup>®</sup>\n\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\tin the pharmaceutical form of a\n\t\t\t\t\t\t\t\t\t“solution for subcutaneous injection”])\n\t\t\t\t\t\t\t\t</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tThe single dose of the medicinal product is 50 mg. The medicinal\n\t\t\t\t\t\t\t\tproduct is injected once a week, and the duration of therapy is not more\n\t\t\t\t\t\t\t\tthan 24 weeks. The injections of the medicinal product should be\n\t\t\t\t\t\t\t\tdiscontinued if, after 12 weeks of treatment, no response to the therapy\n\t\t\t\t\t\t\t\tis observed.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tIf repeated administration of Enbrel<sup>®</sup> is needed, the duration of\n\t\t\t\t\t\t\t\ttreatment stated above should be observed. The single dose of the\n\t\t\t\t\t\t\t\tmedicinal product is 50 mg once a week.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>If a dose is missed at the appointed time,</em> the drug must be\n\t\t\t\t\t\t\t\tinjected as soon as remembered, but only on condition that the next\n\t\t\t\t\t\t\t\tinjection will not be <b>earlier than a day later</b>.\n\t\t\t\t\t\t\t\tOtherwise, the forgotten dose should be skipped. Patients should\n\t\t\t\t\t\t\t\tcontinue to inject the medicine on the usual day (days). If a patient\n\t\t\t\t\t\t\t\tdoes not remember the day that the next injection is due, instruct the\n\t\t\t\t\t\t\t\tpatient not to take a double dose.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Impaired hepatic and renal function:</em> there is no need to\n\t\t\t\t\t\t\t\tadjust the dose.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t</div>"
            }
          },
          {
            "title" : "Instructions for Use",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Instructions for Use"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t<b>below-are-the-instructions-for-preparing-and-injecting-a-solution-for-subcutaneous-injection-of-enbrel-in-syringes-and-injection-pens.</b> Below\n\t\t\t\t\t\t\tare the instructions for preparing and injecting a solution for\n\t\t\t\t\t\t\tsubcutaneous injection of Enbrel<sup>®</sup> in syringes and injection pens.\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<b>selecting-a-site-for-injection</b>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThree sites are recommended for the injection of Enbrel <sup>®</sup>: (1)\n\t\t\t\t\t\t\t\t\t\tthe front surface of the middle third of the thigh; (2) the abdomen,\n\t\t\t\t\t\t\t\t\t\texcept for an area 5 cm in diameter around the navel;\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t(3) the outer surface of the shoulder (see Fig. 1). If you are\n\t\t\t\t\t\t\t\tadministering an injection to yourself, you should not use the outer\n\t\t\t\t\t\t\t\tsurface of the shoulder.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<u>Fig. 1</u>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<img src=\"#image1\" alt=\"Figure 1\"/>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tEach injection should be administered in a different site. The\n\t\t\t\t\t\t\t\t\t\tsite of each new injection should be at least 3 cm away from the site of\n\t\t\t\t\t\t\t\t\t\tthe previous injection. DO NOT INJECT the medicinal product into areas\n\t\t\t\t\t\t\t\t\t\twhere there is pain, skin redness, bruising or induration. Do not inject\n\t\t\t\t\t\t\t\t\t\tin areas with scars or stretch marks. (It may be useful to write down\n\t\t\t\t\t\t\t\t\t\tthe sites of previous injections).\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIf a child has psoriasis, try not to inject the medicinal product\n\t\t\t\t\t\t\t\t\t\tdirectly into raised, thickened or red areas or lesions with flaking\n\t\t\t\t\t\t\t\t\t\t(psoriatic plaques).\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\t\t1) INSTRUCTIONS FOR PREPARATION AND INJECTION OF A SOLUTION FOR SUBCUTANEOUS INJECTION OF ENBREL<sup>®</sup> IN A SYRINGE\n\t\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tPatients or their parents/guardians who are going to perform\n\t\t\t\t\t\t\t\tinjections should be informed of how to do it correctly. In cases where\n\t\t\t\t\t\t\t\tthe patient or his/her parent/guardian performs the future injections by\n\t\t\t\t\t\t\t\thim-/herself, the first injection must be performed under the\n\t\t\t\t\t\t\t\tsupervision of qualified medical personnel.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<b>Preparation for Injection</b>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\t\tThis medicinal product must not be mixed with any other\n\t\t\t\t\t\t\t\t\tmedicinal products in a single syringe or vial!\n\t\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tRemove the carton with pre-filled syringes of Enbrel<sup>®</sup> from the\n\t\t\t\t\t\t\t\t\t\trefrigerator and place it on a clean, well-lit, flat work surface. Take\n\t\t\t\t\t\t\t\t\t\tone pre-filled syringe. Do not shake the syringe. Put the carton with\n\t\t\t\t\t\t\t\t\t\tthe remaining pre-filled syringes back in the refrigerator.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<b>Leave the syringe with a solution of Enbrel</b><sup>®</sup>\n\t\t\t\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\t\t\t\tfor 15 to 30 minutes to allow it to reach room\n\t\t\t\t\t\t\t\t\t\t\ttemperature.\n\t\t\t\t\t\t\t\t\t\t</b> DO NOT REMOVE the cap from the syringe needle\n\t\t\t\t\t\t\t\t\t\tuntil it reaches room temperature. Do not warm up Enbrel<sup>®</sup> by any other means (for example, in a microwave oven or in hot water).\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>Wash your hands with soap and warm water.</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tMake sure that the solution in the syringe is clear or\n\t\t\t\t\t\t\t\t\t\topalescent, colorless to yellow or to light brown, it may contain a small amount of semi-transparent or white amorphous particles. If this is not the case, do not inject the solution. Use a different pre-filled syringe of Enbrel<sup>®</sup>.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tYou will also need: an alcohol wipe, which is included in the\n\t\t\t\t\t\t\t\t\t\tkit, and a cotton ball or gauze pad.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\t\tPreparation of the skin site and injection of the solution of Enbrel<sup>®</sup>\n\t\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tWipe the skin site where you will inject Enbrel<sup>®</sup> in circular\n\t\t\t\t\t\t\t\t\t\tmotions with a clean alcohol wipe. <b>DO NOT TOUCH</b> this\n\t\t\t\t\t\t\t\t\t\tarea until you have completed the injection.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tRemove the cap from the needle by pulling it forcefully from the\n\t\t\t\t\t\t\t\t\t\tsyringe (see Fig. 2). <b>\n\t\t\t\t\t\t\t\t\t\t\tBe careful not to bend or over-twist the\n\t\t\t\t\t\t\t\t\t\t\tcap while removing, so as not to damage the needle.\n\t\t\t\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tWhen removing the cap, a drop of fluid may appear on the tip of\n\t\t\t\t\t\t\t\t\t\tthe needle; this is permissible.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t\t\t<p>Do not touch the needle and do not let it touch any other surface.</p>\n\t\t\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tDo not touch or press on the plunger. This can lead to fluid leaking\n\t\t\t\t\t\t\t\tfrom the syringe.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<u>Fig. 2</u>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<img src=\"#image2\" alt=\"Figure 2\" style=\"width:1.78937in;height:1.78937in\"/>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tWhen a cleaned skin area is completely dry, pinch the skin into a\n\t\t\t\t\t\t\t\t\t\tfold with one hand and hold it. With the other hand, hold the syringe\n\t\t\t\t\t\t\t\t\t\tlike a pencil.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tWith a quick, short motion, direct the needle into the skin at an\n\t\t\t\t\t\t\t\t\t\tangle between 45° and 90° (see Fig. 3). In time you will find the angle\n\t\t\t\t\t\t\t\t\t\tthat is most comfortable for the injection. Try not to push the needle\n\t\t\t\t\t\t\t\t\t\tinto the skin too slowly or with excessive force.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<u>Fig. 3</u>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<img src=\"#image3\" alt=\"Figure 3\"/>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tAfter the needle has fully entered the skin, release the fold of\n\t\t\t\t\t\t\t\t\t\tskin you have been holding.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tWith your free hand, hold the base of the syringe to stabilize its\n\t\t\t\t\t\t\t\tposition. Then press the plunger to inject all of the solution at a\n\t\t\t\t\t\t\t\t<b>slow</b>, constant speed (see Fig. 4).\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<u>Fig. 4</u>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<img src=\"#image4\" alt=\"Figure 4\" style=\"width:1.88502in;height:1.68625in\"/>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tWhen the syringe is empty, remove the needle from the skin, being\n\t\t\t\t\t\t\t\t\t\tcareful to keep it at the same angle as when it was inserted.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tPress on the injection site with a cotton ball or gauze pad for\n\t\t\t\t\t\t\t\t\t\t10 seconds. A small amount of bleeding may occur. <b>\n\t\t\t\t\t\t\t\t\t\t\tDO NOT\n\t\t\t\t\t\t\t\t\t\t\tWIPE\n\t\t\t\t\t\t\t\t\t\t</b> the injection site. A bandage may be applied.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<b>Waste disposal</b>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThe pre-filled syringe is intended for single use only.\n\t\t\t\t\t\t\t\t\t\t<b>NEVER</b> reuse the syringe and needle.\n\t\t\t\t\t\t\t\t\t\t<b>NEVER</b> recap the needle. Dispose of the needle and\n\t\t\t\t\t\t\t\t\t\tsyringe as instructed by your physician or nurse.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\t\tIf you have questions, please contact a physician or nurse who works with Enbrel<sup>®</sup>.\n\t\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\t\t2) INSTRUCTIONS FOR PREPARATION AND INJECTION OF A SOLUTION FOR SUBCUTANEOUS INJECTION OF ENBREL<sup>®</sup>IN AN INJECTION PEN\n\t\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tDo not attempt to perform an injection by yourself if you have not\n\t\t\t\t\t\t\t\tunderstood how to use the injection pen properly. If you have questions\n\t\t\t\t\t\t\t\tregarding injections, please ask your physician or nurse.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<u>Fig. 5</u>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<u>Pre-filled injection pen</u>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<img src=\"#image5\" alt=\"Figure 5\"/>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\tStep 1. Preparation\n\t\t\t\t\t\t\t\tfor the injection of Enbrel<sup>®</sup>\n\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>Select a clean, well-lit, flat working surface.</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tGather the following items needed for the injection and place them on\n\t\t\t\t\t\t\t\tthe working surface:\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<ol type=\"a\">\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\t\t\t\tOne pre-filled injection pen and one alcohol\n\t\t\t\t\t\t\t\t\t\t\twipe\n\t\t\t\t\t\t\t\t\t\t</b> (take them out of the carton of injection pens that you\n\t\t\t\t\t\t\t\t\t\tstore in the refrigerator). Do not shake the injection pen.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\t\t\t\tOne cotton ball or gauze\n\t\t\t\t\t\t\t\t\t\t\tpad.\n\t\t\t\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\tCheck the expiry date on the injection pen. Do not use the\n\t\t\t\t\t\t\t\t\t\t\t\tinjection pen if the date is past. Consult with your treating\n\t\t\t\t\t\t\t\t\t\t\t\tphysician.\n\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\tAssess the condition of the solution in the injection pen through\n\t\t\t\t\t\t\t\t\t\t\t\tthe transparent inspection window.\n\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ol>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tIt is only permissible to inject a clear or opalescent, colorless to\n\t\t\t\t\t\t\t\tyellow or light brown solution, which may contain a small quantity of\n\t\t\t\t\t\t\t\tsemi-transparent or white amorphous particles. If this is not the case,\n\t\t\t\t\t\t\t\tyou should use a different injection pen and then ask a pharmacist for\n\t\t\t\t\t\t\t\tassistance.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tWithout removing the white needle cap, wait approximately 15 to\n\t\t\t\t\t\t\t\t\t\t30 minutes for the Enbrel<sup>®</sup> solution in the injection pen to warm up to\n\t\t\t\t\t\t\t\t\t\troom temperature. This will make the injection more comfortable. Do not\n\t\t\t\t\t\t\t\t\t\twarm the injection pen by any other method. <b>\n\t\t\t\t\t\t\t\t\t\t\tAlways keep the\n\t\t\t\t\t\t\t\t\t\t\tinjection pen out of reach of children.\n\t\t\t\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tWhile the solution in the injection pen is warming up to room\n\t\t\t\t\t\t\t\t\t\ttemperature, read the information on Step 2 activities (below) and\n\t\t\t\t\t\t\t\t\t\tselect an injection site.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\tStep 2.\n\t\t\t\t\t\t\t\tInjection of Enbrel<sup>®</sup>\n\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tAfter warming the solution up to room temperature for\n\t\t\t\t\t\t\t\t\t\tapproximately 15 to 30 minutes, wash your hands with soap and\n\t\t\t\t\t\t\t\t\t\twater.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tWith circular motions, wipe the area of skin where you are going\n\t\t\t\t\t\t\t\t\t\tto inject Enbrel<sup>®</sup> with a clean alcohol wipe and allow to dry. <b>DO NOT TOUCH</b> this area until you have completed the injection.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tTake the injection pen and remove the white cap by pulling it\n\t\t\t\t\t\t\t\t\t\tstraight toward yourself (see Fig. 7). To avoid damaging the needle,\n\t\t\t\t\t\t\t\t\t\twhich is covered by the cap, do not tilt the cap when removing it, and\n\t\t\t\t\t\t\t\t\t\tdo not attempt to put it back on after removing. After removing the\n\t\t\t\t\t\t\t\t\t\tneedle cap, you will see a purple protective screen, which protrudes\n\t\t\t\t\t\t\t\t\t\tslightly from the edge of the injection pen. The needle itself will\n\t\t\t\t\t\t\t\t\t\tremain inside the injection pen until the moment it is activated. Do not\n\t\t\t\t\t\t\t\t\t\tuse the injection pen if it dropped on the floor after you had removed\n\t\t\t\t\t\t\t\t\t\tthe protective cap from the needle.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<u>Fig. 7</u>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<img src=\"#image7\" alt=\"Figure 7\"/>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tCarefully pinch the skin into a fold between the thumb and index\n\t\t\t\t\t\t\t\t\t\tfinger of your free hand; this will make it easier to administer the\n\t\t\t\t\t\t\t\t\t\tmedicinal product and make it more comfortable. Try not to touch the\n\t\t\t\t\t\t\t\t\t\tprepared surface of the skin.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\t\t\t\tPlace the injection pen at a right angle (90º) to the\n\t\t\t\t\t\t\t\t\t\t\tinjection site and press the open end firmly\n\t\t\t\t\t\t\t\t\t\t</b> against the skin,\n\t\t\t\t\t\t\t\t\t\tso that the protective screen goes fully inside the injection pen. You\n\t\t\t\t\t\t\t\t\t\twill see a slight indentation of the skin (Fig. 8). The injection pen\n\t\t\t\t\t\t\t\t\t\twill be activated only when the protective screen of the needle has\n\t\t\t\t\t\t\t\t\t\tfully gone into the injection pen.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<u>Fig. 8</u>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<img src=\"#image8\" alt=\"Figure 8\"/>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tPress the injection pen firmly against the skin and make sure\n\t\t\t\t\t\t\t\t\t\tthat the purple protective screen has gone completely inside it. To\n\t\t\t\t\t\t\t\t\t\tinject, press at the center of the green button located on the upper\n\t\t\t\t\t\t\t\t\t\tpart of the injection pen (Fig. 9). After pressing the button, you will\n\t\t\t\t\t\t\t\t\t\thear a click. <b>\n\t\t\t\t\t\t\t\t\t\t\tContinue to hold the injection pen pressed firmly\n\t\t\t\t\t\t\t\t\t\t\tto the skin either until the second click or for 10 seconds after the\n\t\t\t\t\t\t\t\t\t\t\tfirst click\n\t\t\t\t\t\t\t\t\t\t</b> (whichever occurs first).\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\t<u>Note:</u>\n\t\t\t\t\t\t\t\t</em> if you cannot start the injection as described\n\t\t\t\t\t\t\t\tabove, press the injection pen more tightly against the skin and press\n\t\t\t\t\t\t\t\tthe green button again.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<u>Fig. 9</u>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<img src=\"#image9\" alt=\"Figure 9\" style=\"width:2.42172in;height:1.62823in\"/>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tAfter the second click (or in 10 seconds), the injection is\n\t\t\t\t\t\t\t\t\t\tcomplete (Fig. 10), and you can release the pressure on the skin (Fig.\n\t\t\t\t\t\t\t\t\t\t11); the purple protective screen will automatically come out and cover\n\t\t\t\t\t\t\t\t\t\tthe needle.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<u>Fig. 10</u>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<img src=\"#image10\" alt=\"Figure 10\" style=\"width:2.20542in;height:1.49635in\"/>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<u>Fig. 11</u>\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<img src=\"#image11\" alt=\"Figure 11\"/>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tWhen this is done, the color of the inspection window of the\n\t\t\t\t\t\t\t\t\t\tinjection pen will change to purple (see Fig. 12), which confirms that\n\t\t\t\t\t\t\t\t\t\tthe dose has been injected correctly. If this does not occur, you should\n\t\t\t\t\t\t\t\t\t\task a physician, nurse or pharmacist for assistance, as there is no\n\t\t\t\t\t\t\t\t\t\tguarantee in this situation that the full dose of Enbrel<sup>®</sup> has been\n\t\t\t\t\t\t\t\t\t\tinjected. Do not attempt to reuse this injection pen, and do not use a\n\t\t\t\t\t\t\t\t\t\tnew injection pen without consulting with a nurse or\n\t\t\t\t\t\t\t\t\t\tpharmacist.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">Fig. 12</p>\n\t\t\t\t\t\t\t<p style=\"text-align: center;\">\n\t\t\t\t\t\t\t\t<img src=\"#image12\" alt=\"Figure 12\"/>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIf drops of blood appear at the injection site, press a cotton\n\t\t\t\t\t\t\t\t\t\tball or gauze pad against the site and hold it for 10 seconds. Do not\n\t\t\t\t\t\t\t\t\t\trub the injection site.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\tStep 3. Disposal of the\n\t\t\t\t\t\t\t\tused injection pen\n\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t\t<ul>\n\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThe injection pen is intended for single use only; therefore, its\n\t\t\t\t\t\t\t\t\t\treuse is not permissible. Used injection pens should be disposed of as\n\t\t\t\t\t\t\t\t\t\tinstructed by a physician, nurse or pharmacist. Do not try to re-attach\n\t\t\t\t\t\t\t\t\t\tthe needle protective cap.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t</ul>\n\t\t\t\t\t\t\t<b>\n\t\t\t\t\t\t\t\tIf\n\t\t\t\t\t\t\t\tyou have questions, please ask a physician, nurse or pharmacist\n\t\t\t\t\t\t\t\texperienced in working with Enbrel<sup>®</sup>.\n\t\t\t\t\t\t\t</b>\n\t\t\t\t\t\t</div>"
            }
          },
          {
            "title" : "Side effects",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "200000029813"
                }
              ],
              "text" : "Side effects"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"/>"
            },
            "section" : [
              {
                "title" : "Summary of the safety profile",
                "code" : {
                  "coding" : [
                    {
                      "system" : "https://www.minzdrav.gov.ru/",
                      "code" : "200000029814"
                    }
                  ],
                  "text" : "Summary of the safety profile"
                },
                "text" : {
                  "status" : "generated",
                  "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<u>Summary of the safety profile</u>\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tThe most commonly reported adverse reactions are injection site\n\t\t\t\t\t\t\t\t\treactions (such as pain, swelling, itching, reddening and bleeding at\n\t\t\t\t\t\t\t\t\tthe puncture site), infections (such as upper respiratory infections,\n\t\t\t\t\t\t\t\t\tbronchitis, bladder infections and skin infections), allergic reactions,\n\t\t\t\t\t\t\t\t\tdevelopment of autoantibodies, itching, and fever.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tSerious adverse reactions have also been reported during the use of\n\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup>. TNF-antagonists, such as etanercept, negatively affect the\n\t\t\t\t\t\t\t\t\timmune system and their use may have a negative effect on the body’s\n\t\t\t\t\t\t\t\t\tdefenses against infections and malignancies. Serious infections affect\n\t\t\t\t\t\t\t\t\tfewer than one in 100 patients treated with Enbrel<sup>®</sup>. Reports have\n\t\t\t\t\t\t\t\t\tincluded fatal and life-threatening infections and sepsis. Various\n\t\t\t\t\t\t\t\t\tmalignancies have also been reported with the use of Enbrel<sup>®</sup>, including\n\t\t\t\t\t\t\t\t\tcancers of the breast, lung, skin and lymph glands (lymphoma).\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tSerious hematological, neurological and autoimmune reactions have\n\t\t\t\t\t\t\t\t\talso been reported. These include rare reports of pancytopenia and very\n\t\t\t\t\t\t\t\t\trare reports of aplastic anemia. Central and peripheral demyelinating\n\t\t\t\t\t\t\t\t\tevents have been seen rarely and very rarely, respectively, with the use\n\t\t\t\t\t\t\t\t\tof Enbrel<sup>®</sup>. There have been rare reports of lupus, lupus-related\n\t\t\t\t\t\t\t\t\tconditions, and vasculitis.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t</div>"
                },
                "section" : [
                  {
                    "title" : "Tabulated list of adverse reactions",
                    "code" : {
                      "coding" : [
                        {
                          "system" : "https://www.minzdrav.gov.ru/",
                          "code" : "200000029814"
                        }
                      ],
                      "text" : "Tabulated list of adverse reactions"
                    },
                    "text" : {
                      "status" : "generated",
                      "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThe following list of adverse reactions is based on experience from\n\t\t\t\t\t\t\t\t\t\tclinical trials and on post- marketing experience.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tWithin the organ system classes, adverse reactions are listed under\n\t\t\t\t\t\t\t\t\t\tthe following categories of frequency (number of patients expected to\n\t\t\t\t\t\t\t\t\t\texperience the reaction): very common (≥ 1/10); common (≥ 1/100 to &lt;\n\t\t\t\t\t\t\t\t\t\t1/10); uncommon (≥ 1/1,000 to &lt; 1/100); rare (≥ 1/10,000 to &lt;\n\t\t\t\t\t\t\t\t\t\t1/1,000); very rare (&lt; 1/10,000); and not known (cannot be estimated\n\t\t\t\t\t\t\t\t\t\tfrom available data).\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<table>\n\t\t\t\t\t\t\t\t\t\t<colgroup>\n\t\t\t\t\t\t\t\t\t\t\t<col style=\"width: 14%\"/>\n\t\t\t\t\t\t\t\t\t\t\t<col style=\"width: 11%\"/>\n\t\t\t\t\t\t\t\t\t\t\t<col style=\"width: 12%\"/>\n\t\t\t\t\t\t\t\t\t\t\t<col style=\"width: 17%\"/>\n\t\t\t\t\t\t\t\t\t\t\t<col style=\"width: 18%\"/>\n\t\t\t\t\t\t\t\t\t\t\t<col style=\"width: 10%\"/>\n\t\t\t\t\t\t\t\t\t\t\t<col style=\"width: 15%\"/>\n\t\t\t\t\t\t\t\t\t\t</colgroup>\n\t\t\t\t\t\t\t\t\t\t<thead>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"header\">\n\t\t\t\t\t\t\t\t\t\t\t\t<th>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<b>System Organ Class</b>\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<b>Very common ≥ 1/10</b>\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<b>Common ≥ 1/100 to &lt; 1/10</b>\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<b>Uncommon ≥ 1/1,000 to &lt; 1/100</b>\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<b>Rare ≥ 1/10,000 to &lt; 1/1,000</b>\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<b>Very rare &lt; 1/10,000</b>\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</th>\n\t\t\t\t\t\t\t\t\t\t\t\t<th>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<b>Frequency not known (cannot be estimated from available data)</b>\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</th>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t</thead>\n\t\t\t\t\t\t\t\t\t\t<tbody>\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"odd\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Infections and infestations</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tInfections (including upper respiratory tract infections, bronchitis,\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tcystitis, skin\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>infections)*</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tSerious infections (including pneumonia, cellulitis, arthritis\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tbacterial, sepsis and parasitic infections)*\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tTuberculosis, opportunistic infection (including invasive fungal,\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tprotozoal, bacterial, atypical mycobacterial, viral infections, and\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<em>Legionella</em>)*\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Hepatitis B reactivation, listeria</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"even\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tNeoplasms benign, malignant and unspecified (including cysts and\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tpolyps)\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Non-melanoma skin cancers* (see “Special warnings” section)</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tMalignant melanoma (see “Special warnings” section), lymphoma,\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tleukemia\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tMerkel cell carcinoma (see “Special warnings” section) Kaposi’s\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsarcoma\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"odd\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Blood and lymphatic system disorders</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Thrombocytopenia, anemia,</p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>leukopenia, neutropenia</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Pancytopenia*</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Aplastic anemia*</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Hematophagy histiocytosis (macrophage activation syndrome)*</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"even\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Immune system disorders</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Allergic reactions</p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t(see Skin and subcutaneous tissue disorders” section), autoantibody\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tformation*\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tVasculitis (including anti- neutrophilic cytoplasmic antibody\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tpositive vasculitis)\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tSerious allergic/anaphylactic reactions (including angioedema,\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tbronchospasm), sarcoidosis\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Worsening of symptoms of dermatomyositis</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"odd\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Nervous system disorders</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Headache*</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tCNS demyelinating events suggestive of multiple sclerosis or\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tlocalized demyelinating conditions, such as optic neuritis and\n\t\t\t\t\t\t\t\t\t\t\t\t\t\ttransverse myelitis (see “Special warnings” section), peripheral\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tdemyelinating events, including Guillain-Barré syndrome, chronic\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tinflammatory demyelinating polyneuropathy, demyelinating polyneuropathy, and multifocal motor neuropathy (see “Special\n\t\t\t\t\t\t\t\t\t\t\t\t\t\twarnings” section), seizure\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"odd\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Eye disorders</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Uveitis, scleritis</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"even\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Cardiac disorders</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tWorsening of congestive heart failure (see “Special warnings”\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsection)\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tNew onset congestive heart failure (see “Special warnings”\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tsection)\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"odd\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Respiratory, thoracic, and mediastinal disorders</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tInterstitial lung disease (including pneumonitis and pulmonary\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tfibrosis)*\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"even\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Gastrointestinal tract disorders</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Inflammatory bowel disease*</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"odd\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Hepatobiliary disorders</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Elevated liver enzymes*</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Autoimmune hepatitis*</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"even\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Skin and subcutaneous tissue disorders</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Pruritus, rash</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tAngioedema, psoriasis (including new onset or worsening and pustular,\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tprimarily palms and soles), urticaria, psoriasiform rash\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tStevens-Johnson syndrome, cutaneous vasculitis (including\n\t\t\t\t\t\t\t\t\t\t\t\t\t\thypersensitivity\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>vasculitis), erythema multiforme, lichenoid reactions</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Toxic epidermal necrolysis</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"odd\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Musculoskeletal and connective tissue disorders</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tCutaneous lupus erythematosus, subacute cutaneous lupus\n\t\t\t\t\t\t\t\t\t\t\t\t\t\terythematosus, lupus-like syndrome\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"even\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>General disorders and administration site conditions</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tInjection site reactions (including bleeding, bruising, erythema,\n\t\t\t\t\t\t\t\t\t\t\t\t\t\titching, pain, swelling)*\n\t\t\t\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Pyrexia</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t\t<td/>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t\t<tr class=\"odd\">\n\t\t\t\t\t\t\t\t\t\t\t\t<td colspan=\"7\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>*see “Description of selected adverse reactions” below.</p>\n\t\t\t\t\t\t\t\t\t\t\t\t</td>\n\t\t\t\t\t\t\t\t\t\t\t</tr>\n\t\t\t\t\t\t\t\t\t\t</tbody>\n\t\t\t\t\t\t\t\t\t</table>\n\t\t\t\t\t\t\t\t</div>"
                    }
                  },
                  {
                    "title" : "Description of selected adverse reactions",
                    "code" : {
                      "coding" : [
                        {
                          "system" : "https://www.minzdrav.gov.ru/",
                          "code" : "200000029814"
                        }
                      ],
                      "text" : "Description of selected adverse reactions"
                    },
                    "text" : {
                      "status" : "generated",
                      "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>Malignancies and lymphoproliferative disorders</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tOne hundred and twenty-nine (129) new malignancies of various types\n\t\t\t\t\t\t\t\t\t\twere observed in 4,114 rheumatoid arthritis patients treated in clinical\n\t\t\t\t\t\t\t\t\t\ttrials with Enbrel<sup>®</sup> for up to approximately six\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tyears, including 231 patients treated with Enbrel<sup>®</sup> in combination\n\t\t\t\t\t\t\t\t\t\twith methotrexate in the two- year active-controlled study. The observed\n\t\t\t\t\t\t\t\t\t\trates and incidences in these clinical trials were similar to those\n\t\t\t\t\t\t\t\t\t\texpected for the population studied. A total of two malignancies were\n\t\t\t\t\t\t\t\t\t\treported in clinical studies of approximately two years duration\n\t\t\t\t\t\t\t\t\t\tinvolving 240 psoriatic arthritis patients who received Enbrel<sup>®</sup>. In\n\t\t\t\t\t\t\t\t\t\tclinical studies conducted for more than two years with 351 ankylosing\n\t\t\t\t\t\t\t\t\t\tspondylitis patients, six malignancies were reported in patients treated\n\t\t\t\t\t\t\t\t\t\twith Enbrel<sup>®</sup>. In a group of 2,711 plaque psoriasis patients treated with\n\t\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> in double-blind and open-label studies of up to 2.5 years, 30\n\t\t\t\t\t\t\t\t\t\tmalignancies and 43 non-melanoma skin cancers were reported.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIn a group of 7,416 patients treated with Enbrel<sup>®</sup> in rheumatoid\n\t\t\t\t\t\t\t\t\t\tarthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis\n\t\t\t\t\t\t\t\t\t\tclinical trials, 18 lymphomas were reported.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tReports of various malignancies (including breast and lung carcinoma\n\t\t\t\t\t\t\t\t\t\tand lymphoma) have also been received in the post-marketing period (see\n\t\t\t\t\t\t\t\t\t\t“Special warnings” section).\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>Injection site reactions</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tCompared to placebo, patients with rheumatic diseases treated with\n\t\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> had a significantly higher incidence of injection site reactions\n\t\t\t\t\t\t\t\t\t\t(36% vs. 9%). Injection site reactions usually occurred in the first\n\t\t\t\t\t\t\t\t\t\tmonth. Mean duration was approximately three to five days. No treatment\n\t\t\t\t\t\t\t\t\t\twas given for the majority of injection site reactions in the groups\n\t\t\t\t\t\t\t\t\t\treceiving Enbrel<sup>®</sup>, and the majority of patients who were given treatment\n\t\t\t\t\t\t\t\t\t\treceived topical preparations, such as corticosteroids, or oral\n\t\t\t\t\t\t\t\t\t\tantihistamines. Additionally, some patients developed recall injection\n\t\t\t\t\t\t\t\t\t\tsite reactions characterized by a skin reaction at the most recent site\n\t\t\t\t\t\t\t\t\t\tof injection, along with the simultaneous appearance of injection site\n\t\t\t\t\t\t\t\t\t\treactions at previous injection sites. These reactions were generally\n\t\t\t\t\t\t\t\t\t\ttransient and did not recur with treatment.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIn controlled trials in patients with plaque psoriasis, approximately\n\t\t\t\t\t\t\t\t\t\t13.6% of patients treated with Enbrel<sup>®</sup> developed injection site\n\t\t\t\t\t\t\t\t\t\treactions compared with 3.4% of placebo-treated patients during the\n\t\t\t\t\t\t\t\t\t\tfirst 12 weeks of treatment.\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>Serious infections</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIn placebo-controlled trials, no increase in the incidence of serious\n\t\t\t\t\t\t\t\t\t\tinfections (fatal, life- threatening, or requiring hospitalization or\n\t\t\t\t\t\t\t\t\t\tintravenous antibiotics) was observed. Serious infections, including\n\t\t\t\t\t\t\t\t\t\tabscess (at various sites), bacteremia, bronchitis, bursitis,\n\t\t\t\t\t\t\t\t\t\tcellulitis, cholecystitis, diarrhea, diverticulitis, endocarditis\n\t\t\t\t\t\t\t\t\t\t(suspected), gastroenteritis, hepatitis B, herpes zoster, leg ulcer,\n\t\t\t\t\t\t\t\t\t\tmouth infection, osteomyelitis, otitis, peritonitis, pneumonia,\n\t\t\t\t\t\t\t\t\t\tpyelonephritis, sepsis, septic arthritis, sinusitis, skin infection,\n\t\t\t\t\t\t\t\t\t\tskin ulcer, urinary tract infection, vasculitis, and wound infection,\n\t\t\t\t\t\t\t\t\t\toccurred in 6.3% of rheumatoid arthritis patients treated with Enbrel<sup>®</sup>\n\t\t\t\t\t\t\t\t\t\tfor up to 48 months. In the two-year active-controlled study where\n\t\t\t\t\t\t\t\t\t\tpatients were treated with either Enbrel alone, methotrexate alone or\n\t\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> in combination with methotrexate, the rates of serious\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tinfections were similar among the treatment groups. However, it\n\t\t\t\t\t\t\t\t\t\tcannot be excluded that the combination of Enbrel<sup>®</sup> with methotrexate\n\t\t\t\t\t\t\t\t\t\tcould be associated with an increase in the rate of infections.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThere were no differences in rates of infection among patients\n\t\t\t\t\t\t\t\t\t\ttreated with Enbrel<sup>®</sup> and those treated with placebo for plaque psoriasis\n\t\t\t\t\t\t\t\t\t\tin placebo-controlled trials lasting up to 24 weeks. Serious infections\n\t\t\t\t\t\t\t\t\t\texperienced by Enbrel<sup>®</sup>-treated patients included cellulitis,\n\t\t\t\t\t\t\t\t\t\tgastroenteritis, pneumonia, cholecystitis, osteomyelitis, gastritis,\n\t\t\t\t\t\t\t\t\t\tappendicitis, <em>Streptococcal</em> fasciitis, myositis, septic shock,\n\t\t\t\t\t\t\t\t\t\tdiverticulitis and abscess. In the double-blind and open-label psoriatic\n\t\t\t\t\t\t\t\t\t\tarthritis trials, one patient reported a serious infection\n\t\t\t\t\t\t\t\t\t\t(pneumonia).\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tSerious and fatal infections have been reported during the use of\n\t\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup>; they were caused by bacteria, mycobacteria (including\n\t\t\t\t\t\t\t\t\t\ttuberculosis), viruses and fungi. Some have occurred within a few weeks\n\t\t\t\t\t\t\t\t\t\tafter initiating treatment with Enbrel<sup>®</sup> in patients who have underlying\n\t\t\t\t\t\t\t\t\t\tconditions (e.g., diabetes mellitus, congestive heart failure, history\n\t\t\t\t\t\t\t\t\t\tof active or chronic infections) in addition to their rheumatoid\n\t\t\t\t\t\t\t\t\t\tarthritis (see “Special warnings” section). Treatment with Enbrel<sup>®</sup> may\n\t\t\t\t\t\t\t\t\t\tincrease mortality in patients with established sepsis.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tOpportunistic infections have been reported in association with\n\t\t\t\t\t\t\t\t\t\ttreatment with Enbrel<sup>®</sup>, including invasive fungal, parasitic (including\n\t\t\t\t\t\t\t\t\t\tprotozoal), viral (including herpes zoster), bacterial (including\n\t\t\t\t\t\t\t\t\t\t<em>Listeria</em> and <em>Legionella</em>), and atypical mycobacterial\n\t\t\t\t\t\t\t\t\t\tinfections. In pooled data from clinical trials, the overall incidence\n\t\t\t\t\t\t\t\t\t\tof opportunistic infections was 0.09% for the 15,402 subjects who\n\t\t\t\t\t\t\t\t\t\treceived Enbrel<sup>®</sup>. The exposure-adjusted incidence rate was 0.06 events\n\t\t\t\t\t\t\t\t\t\tper 100 patient- years. In post-marketing experience, approximately half\n\t\t\t\t\t\t\t\t\t\tof all case reports of opportunistic infections worldwide were invasive\n\t\t\t\t\t\t\t\t\t\tfungal infections. The most commonly reported invasive fungal infections\n\t\t\t\t\t\t\t\t\t\tincluded <em>Candida, Pneumocystis</em> Aspergillus<em>,</em> and\n\t\t\t\t\t\t\t\t\t\t<em>Histoplasma</em>. Invasive fungal infections accounted for more than\n\t\t\t\t\t\t\t\t\t\thalf of the fatalities amongst patients who developed opportunistic\n\t\t\t\t\t\t\t\t\t\tinfections. The majority of the reports with a fatal outcome were in\n\t\t\t\t\t\t\t\t\t\tpatients with <em>Pneumocystis</em> pneumonia, unspecified systemic\n\t\t\t\t\t\t\t\t\t\tfungal infections, and aspergillosis (see “Special warnings”\n\t\t\t\t\t\t\t\t\t\tsection).\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>Formation of autoantibodies</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tAdult patients had serum samples tested for autoantibodies at\n\t\t\t\t\t\t\t\t\t\tmultiple timepoints. Of the rheumatoid arthritis patients evaluated for\n\t\t\t\t\t\t\t\t\t\tantinuclear antibodies (ANA), the percentage of patients who developed\n\t\t\t\t\t\t\t\t\t\tnew positive ANA (≥ 1:40) was higher in patients treated with Enbrel<sup>®</sup>\n\t\t\t\t\t\t\t\t\t\t(11%) than in placebo-treated patients (5%). The percentage of patients\n\t\t\t\t\t\t\t\t\t\twho developed new positive anti- double-stranded DNA antibodies was also\n\t\t\t\t\t\t\t\t\t\thigher by radioimmunoassay (15% of patients treated with Enbrel<sup>®</sup>\n\t\t\t\t\t\t\t\t\t\tcompared to 4% of placebo-treated patients) and by <em>\n\t\t\t\t\t\t\t\t\t\t\tCrithidia\n\t\t\t\t\t\t\t\t\t\t\tluciliae\n\t\t\t\t\t\t\t\t\t\t</em> assay (3% of patients treated with Enbrel<sup>®</sup> compared to\n\t\t\t\t\t\t\t\t\t\tnone of the placebo-treated patients). The proportion of\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tpatients treated with Enbrel<sup>®</sup> who developed anticardiolipin\n\t\t\t\t\t\t\t\t\t\tantibodies was similarly increased compared to placebo-treated patients.\n\t\t\t\t\t\t\t\t\t\tThe impact of long-term treatment with Enbrel<sup>®</sup> on the development of\n\t\t\t\t\t\t\t\t\t\tautoimmune diseases is unknown.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThere have been rare reports of patients, including rheumatoid factor\n\t\t\t\t\t\t\t\t\t\tpositive patients, who have developed other autoantibodies in\n\t\t\t\t\t\t\t\t\t\tconjunction with a lupus-like syndrome or rashes that are compatible\n\t\t\t\t\t\t\t\t\t\twith subacute cutaneous lupus or discoid lupus by clinical presentation\n\t\t\t\t\t\t\t\t\t\tand biopsy.\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>Pancytopenia and aplastic anemia</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThere have been post-marketing reports of pancytopenia and aplastic\n\t\t\t\t\t\t\t\t\t\tanemia, some of which had fatal outcomes (see “Special warnings”\n\t\t\t\t\t\t\t\t\t\tsection).\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>Interstitial lung disease</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIn controlled clinical trials of etanercept across all indications,\n\t\t\t\t\t\t\t\t\t\tthe frequency (percentage of patients) of interstitial lung disease in\n\t\t\t\t\t\t\t\t\t\tpatients receiving etanercept without concomitant methotrexate was 0.06%\n\t\t\t\t\t\t\t\t\t\t(frequency “rare”). In the controlled clinical trials that allowed\n\t\t\t\t\t\t\t\t\t\tconcomitant treatment with etanercept and methotrexate, the frequency\n\t\t\t\t\t\t\t\t\t\t(percentage of patients) of interstitial lung disease was 0.47%\n\t\t\t\t\t\t\t\t\t\t(frequency “uncommon”). There have been post-marketing reports of\n\t\t\t\t\t\t\t\t\t\tinterstitial lung disease (including pneumonitis and pulmonary\n\t\t\t\t\t\t\t\t\t\tfibrosis), some of which had fatal outcomes.\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>Concurrent treatment with anakinra</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIn studies when adult patients received concurrent treatment with\n\t\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> plus anakinra, a higher rate of serious infections compared to\n\t\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> alone was observed and 2% of patients (3/139) developed\n\t\t\t\t\t\t\t\t\t\tneutropenia (absolute neutrophil count &lt; 1000/mm3). While\n\t\t\t\t\t\t\t\t\t\tneutropenic, one patient developed cellulitis that resolved after\n\t\t\t\t\t\t\t\t\t\thospitalization (see “Special warnings” and “Interaction with other\n\t\t\t\t\t\t\t\t\t\tmedicinal products” sections).\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>Elevated liver enzymes</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIn the double-blind periods of controlled clinical trials of\n\t\t\t\t\t\t\t\t\t\tetanercept across all indications, the frequency (percentage of\n\t\t\t\t\t\t\t\t\t\tpatients) of adverse events of elevated liver enzymes in patients\n\t\t\t\t\t\t\t\t\t\treceiving etanercept without concomitant methotrexate was 0.54%\n\t\t\t\t\t\t\t\t\t\t(frequency “uncommon”). In the double- blind periods of controlled\n\t\t\t\t\t\t\t\t\t\tclinical trials that allowed concomitant treatment with etanercept and\n\t\t\t\t\t\t\t\t\t\tmethotrexate, the frequency (percentage of patients) of adverse events\n\t\t\t\t\t\t\t\t\t\tof elevated liver enzymes was 4.18% (frequency “common”).\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>Autoimmune hepatitis</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIn controlled clinical trials of etanercept across all indications,\n\t\t\t\t\t\t\t\t\t\tthe frequency (percentage of patients) of autoimmune hepatitis in\n\t\t\t\t\t\t\t\t\t\tpatients receiving etanercept without concomitant methotrexate was 0.02%\n\t\t\t\t\t\t\t\t\t\t(frequency “rare”). In the controlled clinical trials that allowed\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tconcomitant treatment with etanercept and methotrexate, the frequency\n\t\t\t\t\t\t\t\t\t\t(incidence proportion) of autoimmune hepatitis was 0.24% (frequency\n\t\t\t\t\t\t\t\t\t\t“uncommon”).\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</div>"
                    }
                  },
                  {
                    "title" : "Adverse reactions in children",
                    "code" : {
                      "coding" : [
                        {
                          "system" : "https://www.minzdrav.gov.ru/",
                          "code" : "200000029814"
                        }
                      ],
                      "text" : "Adverse reactions in children"
                    },
                    "text" : {
                      "status" : "generated",
                      "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\t\t\tAdverse events in pediatric patients with juvenile idiopathic\n\t\t\t\t\t\t\t\t\t\t\tarthritis\n\t\t\t\t\t\t\t\t\t\t</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIn general, the adverse events in pediatric patients with juvenile\n\t\t\t\t\t\t\t\t\t\tidiopathic arthritis were similar in frequency and type to those seen in\n\t\t\t\t\t\t\t\t\t\tadult patients. Differences from adults and other special considerations\n\t\t\t\t\t\t\t\t\t\tare discussed in the following paragraphs.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThe types of infections seen in clinical trials in juvenile\n\t\t\t\t\t\t\t\t\t\tidiopathic arthritis patients aged 2 to 18 years were generally mild to\n\t\t\t\t\t\t\t\t\t\tmoderate and consistent with those commonly seen in outpatient pediatric\n\t\t\t\t\t\t\t\t\t\tpopulations. Severe adverse events reported included varicella with\n\t\t\t\t\t\t\t\t\t\tsigns and symptoms of aseptic meningitis, which resolved without\n\t\t\t\t\t\t\t\t\t\tsequelae (see also “Special warnings” section), appendicitis,\n\t\t\t\t\t\t\t\t\t\tgastroenteritis, depression/personality disorder, cutaneous ulcer,\n\t\t\t\t\t\t\t\t\t\tesophagitis/gastritis, group A streptococcal septic shock, type I\n\t\t\t\t\t\t\t\t\t\tdiabetes mellitus, and soft tissue and post-operative wound\n\t\t\t\t\t\t\t\t\t\tinfection.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIn one study in children with juvenile idiopathic arthritis aged 4 to\n\t\t\t\t\t\t\t\t\t\t17 years, 43 of 69 (62%) children experienced an infection while\n\t\t\t\t\t\t\t\t\t\treceiving Enbrel<sup>®</sup> after three months of the study (part 1, open-label),\n\t\t\t\t\t\t\t\t\t\tand the frequency and severity of infections were similar in 58 patients\n\t\t\t\t\t\t\t\t\t\tcompleting 12 months of open-label extension therapy. The types and\n\t\t\t\t\t\t\t\t\t\tfrequency of adverse events in juvenile idiopathic arthritis patients\n\t\t\t\t\t\t\t\t\t\twere similar to those seen in trials of Enbrel<sup>®</sup> in adult patients with\n\t\t\t\t\t\t\t\t\t\trheumatoid arthritis, and the majority were mild. Several adverse events\n\t\t\t\t\t\t\t\t\t\twere reported more commonly in 69 juvenile idiopathic arthritis patients\n\t\t\t\t\t\t\t\t\t\treceiving Enbrel<sup>®</sup> for three months compared to the 349 adult rheumatoid\n\t\t\t\t\t\t\t\t\t\tarthritis patients. These included headache (19% of patients, 1.7 events\n\t\t\t\t\t\t\t\t\t\tper patient year), nausea (9%, 1.0 event per patient year), abdominal\n\t\t\t\t\t\t\t\t\t\tpain (19%, 0.74 events per patient year), and vomiting (13%, 0.74 events\n\t\t\t\t\t\t\t\t\t\tper patient year).\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThere were four reports of macrophage activation syndrome in juvenile\n\t\t\t\t\t\t\t\t\t\tidiopathic arthritis clinical trials.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tThere have been reports of inflammatory bowel disease and uveitis in\n\t\t\t\t\t\t\t\t\t\tJIA patients treated with Enbrel<sup>®</sup> from post-marketing sources, including\n\t\t\t\t\t\t\t\t\t\ta very small number of cases indicating a positive rechallenge (see\n\t\t\t\t\t\t\t\t\t\t<em>“Special warnings”</em> section).\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\t\t\tAdverse events in pediatric patients with plaque\n\t\t\t\t\t\t\t\t\t\t\tpsoriasis\n\t\t\t\t\t\t\t\t\t\t</em>\n\t\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\tIn a 48-week study in 211 children aged 4 to 17 years with pediatric\n\t\t\t\t\t\t\t\t\t\tplaque psoriasis, the adverse events reported were similar to those seen\n\t\t\t\t\t\t\t\t\t\tin previous studies in adults with plaque psoriasis.\n\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t</div>"
                    }
                  }
                ]
              }
            ]
          },
          {
            "title" : "Overdose",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Overdose"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\tIn the case of an overdose of Enbrel\n\t\t\t\t\t\t\t\t\t\t<sup>®</sup>,\n\t\t\t\t\t\t\t\t</em>\n\t\t\t\t\t\t\t\t<em>\n\t\t\t\t\t\t\t\t\tcontact a physician or pharmacist immediately.\n\t\t\t\t\t\t\t\t</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tSave the carton of Enbrel<sup>®</sup>, even if it is empty.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tThe maximum dose of Enbrel<sup>®</sup> has not been established. In a clinical\n\t\t\t\t\t\t\t\tstudy, a single 60 mg/m2 dose was administered to healthy volunteers,\n\t\t\t\t\t\t\t\twhich did not lead to the development of dose- limiting toxicity.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tIn the treatment of patients with rheumatoid arthritis, no cases of\n\t\t\t\t\t\t\t\tthe toxic dose limit being exceeded were documented. The highest dose\n\t\t\t\t\t\t\t\tinjected intravenously was 32 mg/m2, with a subsequent subcutaneous\n\t\t\t\t\t\t\t\tinjection of 16 mg/m2 twice a week. There is no known specific antidote\n\t\t\t\t\t\t\t\tfor Enbrel<sup>®</sup>.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t</div>"
            }
          },
          {
            "title" : "Interaction with other medicinal products",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Interaction with other medicinal products"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Anakinra</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tDuring combined therapy with etanercept and anakinra, a significant\n\t\t\t\t\t\t\t\tincrease in the frequency of serious infections and neutropenia was\n\t\t\t\t\t\t\t\tobserved as compared with patients who were injected with only\n\t\t\t\t\t\t\t\tetanercept or only anakinra.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tCombined therapy with etanercept and anakinra did not show any\n\t\t\t\t\t\t\t\tclinical benefit and, therefore, is not recommended.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Abatacept</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tThe simultaneous use of abatacept and etanercept was accompanied by\n\t\t\t\t\t\t\t\tan increase in the frequency of serious undesirable events. This drug\n\t\t\t\t\t\t\t\tcombination did not show any clinical benefits and, therefore, is not\n\t\t\t\t\t\t\t\trecommended.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Sulfasalazine</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tIn patients administered etanercept during treatment with\n\t\t\t\t\t\t\t\tsulfasalazine, a significant reduction in leukocyte count was documented\n\t\t\t\t\t\t\t\tcompared to patients who received only etanercept or only\n\t\t\t\t\t\t\t\tsulfasalazine.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<u>\n\t\t\t\t\t\t\t\t\t<em>Absence</em>\n\t\t\t\t\t\t\t\t\t<em>of</em>\n\t\t\t\t\t\t\t\t\t<em>interaction</em>\n\t\t\t\t\t\t\t\t</u>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tNo adverse interactions were observed during the simultaneous use of\n\t\t\t\t\t\t\t\tetanercept with glucocorticosteroids, salicylates (with the exception of\n\t\t\t\t\t\t\t\tsulfasalazine), non-steroidal anti- inflammatory drugs (NSAIDs),\n\t\t\t\t\t\t\t\tanalgesics or methotrexate.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Methotrexate</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tMethotrexate has no effect on the pharmacokinetics of etanercept. The\n\t\t\t\t\t\t\t\teffect of etanercept on the pharmacokinetics of methotrexate in humans\n\t\t\t\t\t\t\t\thas not been studied.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Digoxin</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tNo clinically significant cross-effect on the pharmacokinetics of\n\t\t\t\t\t\t\t\tetanercept has been found.\n\t\t\t\t\t\t\t</p>\n\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Warfarin</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tNo clinically significant cross-effect on the pharmacokinetics of\n\t\t\t\t\t\t\t\tetanercept has been found.\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<em>Vaccination</em>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tLive vaccines should not be administered during treatment with\n\t\t\t\t\t\t\t\tetanercept. There is no data on the secondary transmission of an\n\t\t\t\t\t\t\t\tinfection through a live vaccine to patients receiving etanercept.\n\t\t\t\t\t\t\t\tBefore beginning treatment with etanercept, it is recommended that\n\t\t\t\t\t\t\t\tchildren and adolescents receive all necessary vaccinations according to\n\t\t\t\t\t\t\t\tthe current national vaccination calendar, if possible.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tAn increase in B-cell immune response to the pneumococcal\n\t\t\t\t\t\t\t\tpolysaccharide vaccine was observed in the majority of patients with\n\t\t\t\t\t\t\t\tpsoriatic arthritis who had received etanercept, even if titers were\n\t\t\t\t\t\t\t\tslightly lower on the whole. A twofold increase in titers was observed\n\t\t\t\t\t\t\t\tin a lower number of patients in comparison with patients not receiving\n\t\t\t\t\t\t\t\tetanercept.\n\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t</div>"
            },
            "section" : [
              {
                "title" : "Special warnings",
                "code" : {
                  "coding" : [
                    {
                      "system" : "https://www.minzdrav.gov.ru/",
                      "code" : "100000155538"
                    }
                  ],
                  "text" : "Special warnings"
                },
                "text" : {
                  "status" : "generated",
                  "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tAfter the discontinuation of Enbrel<sup>®</sup>, disease symptoms may recur.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Infections</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tPatients should be examined for infections before starting treatment\n\t\t\t\t\t\t\t\t\twith Enbrel<sup>®</sup>, during treatment and after completing the course of\n\t\t\t\t\t\t\t\t\ttreatment, taking into account the mean half-life of etanercept, which\n\t\t\t\t\t\t\t\t\tis approximately 70 hours (seven to 300 hours).\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tDuring treatment with Enbrel<sup>®</sup>, sepsis, tuberculosis, parasitic\n\t\t\t\t\t\t\t\t\tinfections (including those caused by protozoa organisms) and severe\n\t\t\t\t\t\t\t\t\tinfections, including opportunistic infections, such as invasive fungal\n\t\t\t\t\t\t\t\t\tinfections, listeriosis and legionellosis (some with lethal outcomes),\n\t\t\t\t\t\t\t\t\tand viral infections (including caused by herpes zoster) were reported.\n\t\t\t\t\t\t\t\t\tThe most commonly reported invasive fungal infections were caused by\n\t\t\t\t\t\t\t\t\t<em>Candida Pneumocystis, Aspergillus</em> and <em>Histoplasma.</em>\n\t\t\t\t\t\t\t\t\tIncorrect diagnosis of the above-mentioned infections, especially fungal\n\t\t\t\t\t\t\t\t\tand other opportunistic infections, led to the delayed prescription of\n\t\t\t\t\t\t\t\t\tnecessary treatment and, in some cases, to lethal outcomes. In many\n\t\t\t\t\t\t\t\t\tcases, patients received treatment with other medicinal products,\n\t\t\t\t\t\t\t\t\tincluding immunosuppressants. When examining patients, it is important\n\t\t\t\t\t\t\t\t\tto consider the possible development of opportunistic infections, for\n\t\t\t\t\t\t\t\t\texample, endemic mycoses. Patients who develop new infections during\n\t\t\t\t\t\t\t\t\ttreatment with Enbrel<sup>®</sup> should be kept under close observation.\n\t\t\t\t\t\t\t\t\t<b>The administration of Enbrel</b><sup>®</sup> <b>\n\t\t\t\t\t\t\t\t\t\tshould be\n\t\t\t\t\t\t\t\t\t\tdiscontinued if a patient develops a severe infection.\n\t\t\t\t\t\t\t\t\t</b> The\n\t\t\t\t\t\t\t\t\tadministration of Enbrel<sup>®</sup> requires caution in patients with a history of\n\t\t\t\t\t\t\t\t\tfrequent or chronic infections or underlying diseases, which may\n\t\t\t\t\t\t\t\t\tfacilitate the development of infections (such as severe or poorly\n\t\t\t\t\t\t\t\t\tcontrolled diabetes mellitus).\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tThe safety and efficacy of Enbrel<sup>®</sup> in patients with chronic\n\t\t\t\t\t\t\t\t\tinfections have not been evaluated.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Tuberculosis</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tDuring treatment with Enbrel<sup>®</sup>, cases of active tuberculosis have been\n\t\t\t\t\t\t\t\t\treported, including miliary tuberculosis and extrapulmonary\n\t\t\t\t\t\t\t\t\ttuberculosis. Among rheumatoid arthritis patients, there is apparently a\n\t\t\t\t\t\t\t\t\thigher frequency of the development of tuberculosis infection.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tThe development of tuberculosis infection may be connected with the\n\t\t\t\t\t\t\t\t\treactivation of a latent infection or with the development of a new\n\t\t\t\t\t\t\t\t\tinfection.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tBefore starting treatment, all patients should be screened for the\n\t\t\t\t\t\t\t\t\tpresence of active or latent tuberculosis. The screening should include\n\t\t\t\t\t\t\t\t\ta detailed examination of the patient’s medical history with regard to\n\t\t\t\t\t\t\t\t\tcontraction of tuberculosis or contact with tuberculosis patients in the\n\t\t\t\t\t\t\t\t\tpast and information on previous or current immunosuppressive therapy.\n\t\t\t\t\t\t\t\t\tAll patients should undergo necessary screenings in accordance with\n\t\t\t\t\t\t\t\t\tlocal requirements. These must include: a tuberculin skin test and a\n\t\t\t\t\t\t\t\t\tchest x-ray. The possibility of a false negative tuberculin skin test\n\t\t\t\t\t\t\t\t\tshould be considered, especially in patients in a serious condition or\n\t\t\t\t\t\t\t\t\tin immunocompromised patients. It is also necessary to consider the\n\t\t\t\t\t\t\t\t\tpossibility of the development of tuberculosis in patients in whom signs\n\t\t\t\t\t\t\t\t\tof tuberculosis infection were not found before beginning treatment with\n\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup>. The attending physician should monitor the condition of the\n\t\t\t\t\t\t\t\t\tpatient for any signs of tuberculosis, including patients who originally\n\t\t\t\t\t\t\t\t\ttested negative for tuberculosis infection.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> should not be used if a patient has active tuberculosis. If\n\t\t\t\t\t\t\t\t\tinactive tuberculosis is present before beginning the treatment with\n\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup>, a standard anti-tuberculosis therapy should be prescribed in\n\t\t\t\t\t\t\t\t\taccordance with local recommendations. In this case, the benefit-to-risk\n\t\t\t\t\t\t\t\t\tratio of treatment with Enbrel<sup>®</sup> should be thoroughly analyzed.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tAll patients should be advised to contact a physician if symptoms\n\t\t\t\t\t\t\t\t\ttypical of tuberculosis (for example, persistent cough, weight loss,\n\t\t\t\t\t\t\t\t\tlow-grade fever) appear during or after treatment with Enbrel<sup>®</sup>.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Activation of hepatitis B virus</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tCases of the activation of hepatitis B virus in carrier patients who\n\t\t\t\t\t\t\t\t\treceived TNF inhibitors, including Enbrel<sup>®</sup>, have been reported. The\n\t\t\t\t\t\t\t\t\tmajority of these cases took place in patients who had simultaneously\n\t\t\t\t\t\t\t\t\tbeen receiving other medicinal products that suppress the immune system\n\t\t\t\t\t\t\t\t\tand could also promote the reactivation of hepatitis B virus. Before\n\t\t\t\t\t\t\t\t\tusing Enbrel<sup>®</sup> in patients with a high risk of contracting hepatitis B,\n\t\t\t\t\t\t\t\t\tappropriate diagnostic screening should be conducted. Despite the fact\n\t\t\t\t\t\t\t\t\tthat no connection with the use of Enbrel<sup>®</sup> has been proven, special care\n\t\t\t\t\t\t\t\t\tshould be taken when using Enbrel<sup>®</sup> in patients who are carriers of\n\t\t\t\t\t\t\t\t\thepatitis B virus. It is necessary to monitor the condition of patients\n\t\t\t\t\t\t\t\t\tfor signs of hepatitis B. If symptoms of the disease appear, the\n\t\t\t\t\t\t\t\t\tpossibility of specific therapy should be discussed.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Exacerbation of hepatitis C</em>\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tCases of the exacerbation of hepatitis C have been documented in\n\t\t\t\t\t\t\t\t\tpatients receiving treatment with Enbrel<sup>®</sup>; however, no cause-and-effect\n\t\t\t\t\t\t\t\t\trelationship with the use of etanercept has been proven. Nevertheless,\n\t\t\t\t\t\t\t\t\tcaution should be exercised when administering Enbrel<sup>®</sup> to patients with\n\t\t\t\t\t\t\t\t\ta history of hepatitis C.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Allergic reactions</em>\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tThe use of Enbrel<sup>®</sup> is frequently accompanied by allergic reactions.\n\t\t\t\t\t\t\t\t\t<u>In case of any severe allergic</u> or anaphylactic reactions,\n\t\t\t\t\t\t\t\t\ttreatment with Enbrel<sup>®</sup> should be discontinued immediately, and\n\t\t\t\t\t\t\t\t\tappropriate treatment should be started.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tThe protective cap of the injection pen contains latex (dry natural\n\t\t\t\t\t\t\t\t\trubber). Patients or caregivers should consult their physician before\n\t\t\t\t\t\t\t\t\ttaking Enbrel<sup>®</sup> when the needle protective cap is handled by or when\n\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> is administered to a patient with known or possible latex\n\t\t\t\t\t\t\t\t\tsensitivity (allergy).\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Immunosuppression</em>\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tDuring treatment with TNF inhibitors, including Enbrel<sup>®</sup>, there is a\n\t\t\t\t\t\t\t\t\tpossibility of suppressing the body’s defense mechanisms against\n\t\t\t\t\t\t\t\t\tinfections and malignant neoplasms, since TNF is involved in\n\t\t\t\t\t\t\t\t\tinflammation processes and modulates cellular immune responses. However,\n\t\t\t\t\t\t\t\t\tin adult patients with rheumatoid arthritis, there was no evidence of\n\t\t\t\t\t\t\t\t\tdepressed delayed-type hypersensitivity reactions, decreased\n\t\t\t\t\t\t\t\t\timmunoglobulin levels or changes in the effector cell population size\n\t\t\t\t\t\t\t\t\tduring treatment with Enbrel<sup>®</sup>.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tIn rare cases, children with juvenile idiopathic polyarthritis\n\t\t\t\t\t\t\t\t\tdeveloped varicella infection and symptoms of aseptic meningitis, which\n\t\t\t\t\t\t\t\t\tresolved with no complications. Patients who have been in contact with\n\t\t\t\t\t\t\t\t\tvaricella virus should temporarily discontinue Enbrel<sup>®</sup> and start\n\t\t\t\t\t\t\t\t\tprophylactic treatment with immune globulin to <em>\n\t\t\t\t\t\t\t\t\t\tVaricella\n\t\t\t\t\t\t\t\t\t\tZoster\n\t\t\t\t\t\t\t\t\t</em>.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tThe efficacy and safety of Enbrel<sup>®</sup> in patients with immunosuppression\n\t\t\t\t\t\t\t\t\thave not been studied.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Malignant and lymphoproliferative diseases</em>\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tIn the post-marketing period (see “Side effects” section), reports of\n\t\t\t\t\t\t\t\t\tvarious malignant neoplasms (including breast and lung carcinoma and\n\t\t\t\t\t\t\t\t\tlymphoma) were received.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tIn a number of controlled clinical studies, lymphoma was diagnosed\n\t\t\t\t\t\t\t\t\tmore frequently in patients taking TNF inhibitors compared to patients\n\t\t\t\t\t\t\t\t\twho did not receive them. However, these cases were rare, and the\n\t\t\t\t\t\t\t\t\tobservation period for the patients in the placebo group was shorter\n\t\t\t\t\t\t\t\t\tthan for the patients receiving treatment with TNF inhibitors. There are\n\t\t\t\t\t\t\t\t\treports of the development of leukemia in patients undergoing treatment\n\t\t\t\t\t\t\t\t\twith TNF inhibitors. There is a high risk of lymphoma and leukemia\n\t\t\t\t\t\t\t\t\tdeveloping in patients with rheumatoid arthritis – a long-term disease\n\t\t\t\t\t\t\t\t\tcharacterized by active inflammation, which in itself complicates risk\n\t\t\t\t\t\t\t\t\tevaluation. A subsequent analysis of the clinical studies of etanercept\n\t\t\t\t\t\t\t\t\tin patients with rheumatoid arthritis did not confirm or exclude an\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tincrease in the risk of developing cancers in patients who receive\n\t\t\t\t\t\t\t\t\tetanercept. However, based on current data, the possible risk of\n\t\t\t\t\t\t\t\t\tdeveloping lymphomas, leukemia or other malignant neoplasms cannot be\n\t\t\t\t\t\t\t\t\truled out in patients receiving TNF inhibitors.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tMalignant neoplasms (in half of the cases, Hodgkin’s and\n\t\t\t\t\t\t\t\t\tnon-Hodgkin’s lymphomas), some of which had lethal outcomes, were\n\t\t\t\t\t\t\t\t\treported in children and adolescents who had received treatment with TNF\n\t\t\t\t\t\t\t\t\tinhibitors, including Enbrel<sup>®</sup>. The majority of patients received\n\t\t\t\t\t\t\t\t\tconcomitant treatment with immunosuppressants. In other cases, there\n\t\t\t\t\t\t\t\t\twere various malignant neoplasms, including rare varieties, linked with\n\t\t\t\t\t\t\t\t\timmunosuppression. During the use of the medicinal product, it is\n\t\t\t\t\t\t\t\t\tnecessary to consider the risk of developing malignant neoplasms.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Skin cancer</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tMelanoma and non-melanoma skin cancer (NMSC) were documented in\n\t\t\t\t\t\t\t\t\tpatients who had received treatment with TNF inhibitors, including\n\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup>. NMSC is most frequently diagnosed in psoriasis patients. The\n\t\t\t\t\t\t\t\t\tdevelopment of Merkel cell carcinoma has been reported.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tFor all patients at high risk, periodic skin examinations are\n\t\t\t\t\t\t\t\t\trecommended.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Formation of autoimmune antibodies</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tTreatment with Enbrel<sup>®</sup> may be accompanied by the formation of\n\t\t\t\t\t\t\t\t\tautoimmune antibodies (see “Side effects” section). These are not\n\t\t\t\t\t\t\t\t\tneutralizing antibodies and usually disappear shortly. No correlation\n\t\t\t\t\t\t\t\t\thas been observed between the formation of antibodies and the clinical\n\t\t\t\t\t\t\t\t\tefficacy of the medicinal product or the frequency of adverse\n\t\t\t\t\t\t\t\t\treactions.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tIsolated cases of the formation of additional autoantibodies in\n\t\t\t\t\t\t\t\t\tconjunction with lupus-like syndrome or rash similar to a subacute form\n\t\t\t\t\t\t\t\t\tof lupus erythematosus or a discoid form of lupus erythematosus (data\n\t\t\t\t\t\t\t\t\tfrom clinical examination and biopsy) were observed in patients,\n\t\t\t\t\t\t\t\t\tincluding those with rheumatoid arthritis with a positive rheumatoid\n\t\t\t\t\t\t\t\t\tfactor.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Hematological reactions</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tRare cases of pancytopenia and very rare cases of aplastic anemia\n\t\t\t\t\t\t\t\t\twere reported, including lethal cases, in patients who had received\n\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup>. Caution should be exercised when using Enbrel<sup>®</sup> in patients with\n\t\t\t\t\t\t\t\t\ta history of blood disorders. All patients and their\n\t\t\t\t\t\t\t\t\trelatives/caregivers should be advised to seek medical attention\n\t\t\t\t\t\t\t\t\timmediately if a patient develops signs or symptoms typical of an\n\t\t\t\t\t\t\t\t\tinfection or hematological disorders (for example, persistent fever,\n\t\t\t\t\t\t\t\t\ttonsillitis, bruises, bleeding, pallor) when taking Enbrel<sup>®</sup>. These\n\t\t\t\t\t\t\t\t\tpatients should undergo examination immediately, including a complete\n\t\t\t\t\t\t\t\t\tblood count. If the diagnosis of a hematological disorder is confirmed,\n\t\t\t\t\t\t\t\t\ttreatment with Enbrel<sup>®</sup> should be discontinued.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>CNS disorders</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tThere have been rare reports of demyelinating diseases of the CNS in\n\t\t\t\t\t\t\t\t\tpatients receiving treatment with etanercept. There have also been very\n\t\t\t\t\t\t\t\t\trare reports of peripheral demyelinating\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tpolyneuropathies (including Guillain-Barré syndrome). The studies of\n\t\t\t\t\t\t\t\t\ttreatment with Enbrel<sup>®</sup> in patients with multiple sclerosis have not been\n\t\t\t\t\t\t\t\t\tconducted; however, studies of other TNF inhibitors in patients with\n\t\t\t\t\t\t\t\t\tthis condition showed the possibility of its exacerbation. Before\n\t\t\t\t\t\t\t\t\tbeginning the treatment with Enbrel<sup>®</sup>, a thorough evaluation of the\n\t\t\t\t\t\t\t\t\trisk-to-benefit ratio and a neurological assessment are recommended in\n\t\t\t\t\t\t\t\t\tpatients with pre-existing or recent-onset demyelinating diseases as\n\t\t\t\t\t\t\t\t\twell as patients with a high risk of developing a demyelinating\n\t\t\t\t\t\t\t\t\tdisease.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>CHF</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tCaution should be exercised in prescribing Enbrel<sup>®</sup> for patients with\n\t\t\t\t\t\t\t\t\tCHF. Rare (&lt; 0.1%) cases of CHF were reported, including those in\n\t\t\t\t\t\t\t\t\tpatients without a confirmed underlying cardiovascular disease. Some\n\t\t\t\t\t\t\t\t\tpatients were under 50 years old. The data from a number of studies\n\t\t\t\t\t\t\t\t\tsuggest the possibility of exacerbation of CHF in patients receiving\n\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup>.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Combination therapy</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tThe combination of Enbrel<sup>®</sup> and methotrexate yielded no unexpected\n\t\t\t\t\t\t\t\t\tresults in safety testing. The long-term study of this combination\n\t\t\t\t\t\t\t\t\tcontinues. Data on the safety of Enbrel<sup>®</sup> prescribed in combination with\n\t\t\t\t\t\t\t\t\tmethotrexate were similar to those from reports on the use of either\n\t\t\t\t\t\t\t\t\tEnbrel<sup>®</sup> or methotrexate alone. The long-term safety of taking Enbrel<sup>®</sup> in\n\t\t\t\t\t\t\t\t\tcombination with other disease- modifying anti-rheumatic drugs has not\n\t\t\t\t\t\t\t\t\tbeen studied.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tNo studies on Enbrel<sup>®</sup> in combination with other systemic therapy or\n\t\t\t\t\t\t\t\t\tphototherapy for psoriasis have been conducted.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Wegener’s granulomatosis</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tThe frequency of developing various types of malignant extracutaneous\n\t\t\t\t\t\t\t\t\ttumors was significantly higher in patients with Wegener’s\n\t\t\t\t\t\t\t\t\tgranulomatosis who had received Enbrel<b>\n\t\t\t\t\t\t\t\t\t\t<sup>®</sup>\n\t\t\t\t\t\t\t\t\t</b> than in the\n\t\t\t\t\t\t\t\t\tcontrol group.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tTherefore, Enbrel<b>\n\t\t\t\t\t\t\t\t\t\t<sup>®</sup>\n\t\t\t\t\t\t\t\t\t</b> is not recommended for the\n\t\t\t\t\t\t\t\t\ttreatment of Wegener’s granulomatosis patients.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Alcoholic hepatitis</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tThe administration of etanercept for the treatment of alcoholic\n\t\t\t\t\t\t\t\t\thepatitis is not recommended.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Hypoglycemia in patients with diabetes mellitus</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tThere have been reports of hypoglycemia during treatment with Enbrel<sup>®</sup>\n\t\t\t\t\t\t\t\t\tin patients taking hypoglycemic medications, requiring their dose\n\t\t\t\t\t\t\t\t\tadjustment.\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t<em>Effect on the ability to drive and operate machinery</em>\n\t\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tNo studies on the effect of Enbrel<sup>®</sup> on the ability to drive motor\n\t\t\t\t\t\t\t\t\tvehicles and operate complex machinery have been conducted. Therefore,\n\t\t\t\t\t\t\t\t\tcaution should be exercised when driving or operating machinery.\n\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t</div>"
                }
              },
              {
                "title" : "How supplied",
                "code" : {
                  "coding" : [
                    {
                      "system" : "https://www.minzdrav.gov.ru/",
                      "code" : "100000155538"
                    }
                  ],
                  "text" : "How supplied"
                },
                "text" : {
                  "status" : "generated",
                  "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t<p>50 mg/mL solution for subcutaneous injection.</p>\n\t\t\t\t\t\t\t\t<ol type=\"1\">\n\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t0.5 mL (25 mg) or 1.0 mL (50 mg) of the medicinal product in\n\t\t\t\t\t\t\t\t\t\t\tcolorless glass (type I) single- use syringes fitted with a\n\t\t\t\t\t\t\t\t\t\t\tstainless-steel needle covered with a two-layer cap, a plastic finger\n\t\t\t\t\t\t\t\t\t\t\tgrip and a plunger rod with a rubber seal.\n\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\tFour syringes in a set with four individually wrapped alcohol wipes\n\t\t\t\t\t\t\t\t\t\t\tin a plastic package with a ventilation hole.\n\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\tOne, two or six plastic packages (25 mg) or one, two or three plastic\n\t\t\t\t\t\t\t\t\t\t\tpackages (50 mg) along with Instructions for Use in a carton with or\n\t\t\t\t\t\t\t\t\t\t\twithout a tamper-evident seal.\n\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t\t<li>\n\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\t1.0 mL (50 mg) of the drug in a single-use injection pen with a\n\t\t\t\t\t\t\t\t\t\t\twhite plastic needle cap and a purple protective screen. The syringe\n\t\t\t\t\t\t\t\t\t\t\tinside the pen is of colorless glass (type I) and is fitted with a\n\t\t\t\t\t\t\t\t\t\t\tstainless-steel needle.\n\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\t\t\tFour injection pens in a set with four individually wrapped alcohol\n\t\t\t\t\t\t\t\t\t\t\twipes in a plastic package with an air vent. One plastic package with\n\t\t\t\t\t\t\t\t\t\t\tInstructions for Use in a carton with or without a tamper-evident\n\t\t\t\t\t\t\t\t\t\t\tseal.\n\t\t\t\t\t\t\t\t\t\t</p>\n\t\t\t\t\t\t\t\t\t</li>\n\t\t\t\t\t\t\t\t</ol>\n\t\t\t\t\t\t\t</div>"
                }
              },
              {
                "title" : "Storage conditions",
                "code" : {
                  "coding" : [
                    {
                      "system" : "https://www.minzdrav.gov.ru/",
                      "code" : "100000155538"
                    }
                  ],
                  "text" : "Storage conditions"
                },
                "text" : {
                  "status" : "generated",
                  "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t\tStore between 2 °C and 8 °C. Do not freeze. \n\t\t\t\t\t\t\t\t</p>\n                <p>Keep out of reach of children!</p>\n\t\t\t\t\t\t\t</div>"
                }
              }
            ]
          },
          {
            "title" : "Shelf life",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Shelf life"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t<p>Three years.</p>\n\t\t\t\t\t\t\t<p>Do not use after the expiry date indicated on the package!</p>\n\t\t\t\t\t\t</div>"
            },
            "section" : [
              {
                "title" : "Dispensing conditions",
                "code" : {
                  "coding" : [
                    {
                      "system" : "https://www.minzdrav.gov.ru/",
                      "code" : "100000155538"
                    }
                  ],
                  "text" : "Dispensing conditions"
                },
                "text" : {
                  "status" : "generated",
                  "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t\t<p>Dispensed by prescription.</p>\n\t\t\t\t\t\t\t</div>"
                }
              }
            ]
          },
          {
            "title" : "Manufacturer",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Manufacturer"
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t\t\t\t\t\t<p>Pfizer Manufacturing Belgium NV, Belgium</p>\n\t\t\t\t\t\t\t<p>Address: 12 Rijksweg, 2870 Puurs-Sint-Amands, Belgium</p>\n\t\t\t\t\t\t</div>"
            }
          },
          {
            "title" : "Marketing Authorization Holder ",
            "code" : {
              "coding" : [
                {
                  "system" : "https://www.minzdrav.gov.ru/",
                  "code" : "100000155538"
                }
              ],
              "text" : "Marketing Authorization Holder "
            },
            "text" : {
              "status" : "generated",
              "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n              <p><b>Pfizer Inc, USA</b></p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\t<b>Organization receiving consumer claims</b>\n\t\t\t\t\t\t\t</p>\n\n\t\t\t\t\t\t\t<p>Pfizer Innovations LLC</p>\n\n\t\t\t\t\t\t\t<p>123112, Moscow, Presnenskaya nab., d. 10,</p>\n\t\t\t\t\t\t\t<p>\n\t\t\t\t\t\t\t\tBTs [Business Centre] “Bashnya na Naberezhnoy” (Blok C) \n\t\t\t\t\t\t\t</p>\n              <p>Phone: + 7 (495) 287-5000</p>\n\t\t\t\t\t\t\t<p>Fax: +7 (495) 287-5300/287-5067</p>\n\t\t\t\t\t\t</div>"
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "Ingredient/etanercept50mg",
      "resource" : {
        "resourceType" : "Ingredient",
        "id" : "etanercept50mg",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_etanercept50mg\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"etanercept50mg\"> </a><a name=\"hcetanercept50mg\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient &quot;etanercept50mg&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/OP401G7OJC\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><p><b>role</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072072)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Manufacturer</b></td></tr><tr><td style=\"display: none\">*</td><td>See on this page: Organization/orgpfizerbe</td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>ETANERCEPT <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#OP401G7OJC)</span></td></tr></table><h3>Strengths</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td style=\"display: none\">*</td><td>50 mg</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html\">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>"
        },
        "identifier" : {
          "use" : "official",
          "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
          "value" : "OP401G7OJC"
        },
        "status" : "active",
        "for" : [
          {
            "reference" : "ManufacturedItemDefinition/mid50mg"
          }
        ],
        "role" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "100000072072",
              "display" : "Active"
            }
          ]
        },
        "allergenicIndicator" : false,
        "manufacturer" : [
          {
            "manufacturer" : {
              "reference" : "Organization/orgpfizerbe"
            }
          }
        ],
        "substance" : {
          "code" : {
            "concept" : {
              "coding" : [
                {
                  "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
                  "code" : "OP401G7OJC",
                  "display" : "ETANERCEPT"
                }
              ]
            }
          },
          "strength" : [
            {
              "presentationQuantity" : {
                "value" : 50,
                "unit" : "mg"
              },
              "basis" : {
                "coding" : [
                  {
                    "system" : "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
                    "code" : "ACTIB"
                  }
                ],
                "text" : "active ingredient - basis of strength"
              }
            }
          ]
        }
      }
    },
    {
      "fullUrl" : "Ingredient/ingredientARGININEHYDROCHLORIDE",
      "resource" : {
        "resourceType" : "Ingredient",
        "id" : "ingredientARGININEHYDROCHLORIDE",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredientARGININEHYDROCHLORIDE\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredientARGININEHYDROCHLORIDE\"> </a><a name=\"hcingredientARGININEHYDROCHLORIDE\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient &quot;ingredientARGININEHYDROCHLORIDE&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/F7LTH1E20Y\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Manufacturer</b></td></tr><tr><td style=\"display: none\">*</td><td>See on this page: Organization/orgpfizerbe</td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>ARGININE HYDROCHLORIDE <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#F7LTH1E20Y)</span></td></tr></table></blockquote></div>"
        },
        "identifier" : {
          "use" : "official",
          "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
          "value" : "F7LTH1E20Y"
        },
        "status" : "active",
        "for" : [
          {
            "reference" : "ManufacturedItemDefinition/mid50mg"
          }
        ],
        "role" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "100000072082",
              "display" : "Excipient"
            }
          ]
        },
        "allergenicIndicator" : false,
        "manufacturer" : [
          {
            "manufacturer" : {
              "reference" : "Organization/orgpfizerbe"
            }
          }
        ],
        "substance" : {
          "code" : {
            "concept" : {
              "coding" : [
                {
                  "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
                  "code" : "F7LTH1E20Y",
                  "display" : "ARGININE HYDROCHLORIDE"
                }
              ]
            }
          }
        }
      }
    },
    {
      "fullUrl" : "Ingredient/ingredientSodiumChloride",
      "resource" : {
        "resourceType" : "Ingredient",
        "id" : "ingredientSodiumChloride",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredientSodiumChloride\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredientSodiumChloride\"> </a><a name=\"hcingredientSodiumChloride\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient &quot;ingredientSodiumChloride&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/451W47IQ8X\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Manufacturer</b></td></tr><tr><td style=\"display: none\">*</td><td>See on this page: Organization/orgpfizerbe</td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Sodium Chloride <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#451W47IQ8X)</span></td></tr></table></blockquote></div>"
        },
        "identifier" : {
          "use" : "official",
          "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
          "value" : "451W47IQ8X"
        },
        "status" : "active",
        "for" : [
          {
            "reference" : "ManufacturedItemDefinition/mid50mg"
          }
        ],
        "role" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "100000072082",
              "display" : "Excipient"
            }
          ]
        },
        "allergenicIndicator" : false,
        "manufacturer" : [
          {
            "manufacturer" : {
              "reference" : "Organization/orgpfizerbe"
            }
          }
        ],
        "substance" : {
          "code" : {
            "concept" : {
              "coding" : [
                {
                  "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
                  "code" : "451W47IQ8X",
                  "display" : "Sodium Chloride"
                }
              ]
            }
          }
        }
      }
    },
    {
      "fullUrl" : "Ingredient/ingredientSucrose",
      "resource" : {
        "resourceType" : "Ingredient",
        "id" : "ingredientSucrose",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredientSucrose\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredientSucrose\"> </a><a name=\"hcingredientSucrose\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient &quot;ingredientSucrose&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/C151H8M554\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Manufacturer</b></td></tr><tr><td style=\"display: none\">*</td><td>See on this page: Organization/orgpfizerbe</td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>Sucrose <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#C151H8M554)</span></td></tr></table><h3>Strengths</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Basis</b></td></tr><tr><td style=\"display: none\">*</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html\">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>"
        },
        "identifier" : {
          "use" : "official",
          "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
          "value" : "C151H8M554"
        },
        "status" : "active",
        "for" : [
          {
            "reference" : "ManufacturedItemDefinition/mid50mg"
          }
        ],
        "role" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "100000072082",
              "display" : "Excipient"
            }
          ]
        },
        "allergenicIndicator" : false,
        "manufacturer" : [
          {
            "manufacturer" : {
              "reference" : "Organization/orgpfizerbe"
            }
          }
        ],
        "substance" : {
          "code" : {
            "concept" : {
              "coding" : [
                {
                  "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
                  "code" : "C151H8M554",
                  "display" : "Sucrose"
                }
              ]
            }
          },
          "strength" : [
            {
              "basis" : {
                "coding" : [
                  {
                    "system" : "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
                    "code" : "ACTIB",
                    "display" : "active ingredient - basis of strength"
                  }
                ]
              }
            }
          ]
        }
      }
    },
    {
      "fullUrl" : "Ingredient/ingredientsodiumdihydrogenphosphatedihydrate",
      "resource" : {
        "resourceType" : "Ingredient",
        "id" : "ingredientsodiumdihydrogenphosphatedihydrate",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredientsodiumdihydrogenphosphatedihydrate\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredientsodiumdihydrogenphosphatedihydrate\"> </a><a name=\"hcingredientsodiumdihydrogenphosphatedihydrate\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient &quot;ingredientsodiumdihydrogenphosphatedihydrate&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/5QWK665956\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Manufacturer</b></td></tr><tr><td style=\"display: none\">*</td><td>See on this page: Organization/orgpfizerbe</td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>sodium dihydrogen phosphate dihydrate  <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#5QWK665956)</span></td></tr></table><h3>Strengths</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Basis</b></td></tr><tr><td style=\"display: none\">*</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html\">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>"
        },
        "identifier" : {
          "use" : "official",
          "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
          "value" : "5QWK665956"
        },
        "status" : "active",
        "for" : [
          {
            "reference" : "ManufacturedItemDefinition/mid50mg"
          }
        ],
        "role" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "100000072082",
              "display" : "Excipient"
            }
          ]
        },
        "allergenicIndicator" : false,
        "manufacturer" : [
          {
            "manufacturer" : {
              "reference" : "Organization/orgpfizerbe"
            }
          }
        ],
        "substance" : {
          "code" : {
            "concept" : {
              "coding" : [
                {
                  "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
                  "code" : "5QWK665956",
                  "display" : "sodium dihydrogen phosphate dihydrate "
                }
              ]
            }
          },
          "strength" : [
            {
              "basis" : {
                "coding" : [
                  {
                    "system" : "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
                    "code" : "ACTIB",
                    "display" : "active ingredient - basis of strength"
                  }
                ]
              }
            }
          ]
        }
      }
    },
    {
      "fullUrl" : "Ingredient/ingredientWATERFORINJECTION",
      "resource" : {
        "resourceType" : "Ingredient",
        "id" : "ingredientWATERFORINJECTION",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_ingredientWATERFORINJECTION\"> </a><p><b>Generated Narrative: Ingredient</b><a name=\"ingredientWATERFORINJECTION\"> </a><a name=\"hcingredientWATERFORINJECTION\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Ingredient &quot;ingredientWATERFORINJECTION&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html\">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/059QF0KO0R\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><p><b>role</b>: Excipient <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><h3>Manufacturers</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Manufacturer</b></td></tr><tr><td style=\"display: none\">*</td><td>See on this page: Organization/orgpfizerbe</td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td>WATER FOR INJECTION <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (beta#059QF0KO0R)</span></td></tr></table><h3>Strengths</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Basis</b></td></tr><tr><td style=\"display: none\">*</td><td>active ingredient - basis of strength <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html\">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>"
        },
        "identifier" : {
          "use" : "official",
          "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
          "value" : "059QF0KO0R"
        },
        "status" : "active",
        "for" : [
          {
            "reference" : "ManufacturedItemDefinition/mid50mg"
          }
        ],
        "role" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "100000072082",
              "display" : "Excipient"
            }
          ]
        },
        "allergenicIndicator" : false,
        "manufacturer" : [
          {
            "manufacturer" : {
              "reference" : "Organization/orgpfizerbe"
            }
          }
        ],
        "substance" : {
          "code" : {
            "concept" : {
              "coding" : [
                {
                  "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta",
                  "code" : "059QF0KO0R",
                  "display" : "WATER FOR INJECTION"
                }
              ]
            }
          },
          "strength" : [
            {
              "basis" : {
                "coding" : [
                  {
                    "system" : "http://terminology.hl7.org/CodeSystem/v3-RoleClass",
                    "code" : "ACTIB",
                    "display" : "active ingredient - basis of strength"
                  }
                ]
              }
            }
          ]
        }
      }
    },
    {
      "fullUrl" : "SubstanceDefinition/substancetanercept",
      "resource" : {
        "resourceType" : "SubstanceDefinition",
        "id" : "substancetanercept",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"SubstanceDefinition_substancetanercept\"> </a><p><b>Generated Narrative: SubstanceDefinition</b><a name=\"substancetanercept\"> </a><a name=\"hcsubstancetanercept\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource SubstanceDefinition &quot;substancetanercept&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-SubstanceDefinition-uv-epi.html\">SubstanceDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta/</code>/OP401G7OJC\u00a0(use:\u00a0official)</p><p><b>version</b>: 1</p><p><b>status</b>: Validated (UNII) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#1)</span></p><p><b>manufacturer</b>: See on this page: Organization/orgpfizerbe</p><h3>Names</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Name</b></td><td><b>Type</b></td></tr><tr><td style=\"display: none\">*</td><td>Etanercept</td><td>Protein <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#x)</span></td></tr></table></div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
            "value" : "OP401G7OJC"
          }
        ],
        "version" : "1",
        "status" : {
          "coding" : [
            {
              "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
              "code" : "1",
              "display" : "Validated (UNII)"
            }
          ]
        },
        "manufacturer" : [
          {
            "reference" : "Organization/orgpfizerbe"
          }
        ],
        "name" : [
          {
            "name" : "Etanercept",
            "type" : {
              "coding" : [
                {
                  "system" : "https://gsrs.ncats.nih.gov/ginas/app/beta/",
                  "code" : "x",
                  "display" : "Protein"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "ManufacturedItemDefinition/mid50mg",
      "resource" : {
        "resourceType" : "ManufacturedItemDefinition",
        "id" : "mid50mg",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ManufacturedItemDefinition_mid50mg\"> </a><p><b>Generated Narrative: ManufacturedItemDefinition</b><a name=\"mid50mg\"> </a><a name=\"hcmid50mg\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ManufacturedItemDefinition &quot;mid50mg&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ManufacturedItemDefinition-uv-epi.html\">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.minzdrav.gov.ru/</code>/99b900c6-4776-4cde-8125-4f6de8e98b98\u00a0(use:\u00a0official)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Solution for injection <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000073863)</span></p><p><b>unitOfPresentation</b>: Syringe <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000002150)</span></p><p><b>manufacturer</b>: See on this page: Organization/orgpfizerbe</p></div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "system" : "https://www.minzdrav.gov.ru/",
            "value" : "99b900c6-4776-4cde-8125-4f6de8e98b98"
          }
        ],
        "status" : "active",
        "manufacturedDoseForm" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi/",
              "code" : "100000073863",
              "display" : "Solution for injection"
            }
          ]
        },
        "unitOfPresentation" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "200000002150",
              "display" : "Syringe"
            }
          ]
        },
        "manufacturer" : [
          {
            "reference" : "Organization/orgpfizerbe"
          }
        ]
      }
    },
    {
      "fullUrl" : "AdministrableProductDefinition/ap50mg",
      "resource" : {
        "resourceType" : "AdministrableProductDefinition",
        "id" : "ap50mg",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"AdministrableProductDefinition_ap50mg\"> </a><p><b>Generated Narrative: AdministrableProductDefinition</b><a name=\"ap50mg\"> </a><a name=\"hcap50mg\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource AdministrableProductDefinition &quot;ap50mg&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-AdministrableProductDefinition-uv-epi.html\">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.who-umc.org/phpid</code>/identifier</p><p><b>status</b>: active</p><p><b>formOf</b>: See on this page: MedicinalProductDefinition/mp50mg</p><p><b>administrableDoseForm</b>: Solution for injection <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073863)</span></p><p><b>unitOfPresentation</b>: Syringe <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000002150)</span></p><p><b>producedFrom</b>: See on this page: ManufacturedItemDefinition/mid50mg</p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Subcutaneous use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073633)</span></p><h3>TargetSpecies</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td>Human <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000109093)</span></td></tr></table></blockquote></div>"
        },
        "identifier" : [
          {
            "system" : "https://www.who-umc.org/phpid",
            "value" : "identifier"
          }
        ],
        "status" : "active",
        "formOf" : [
          {
            "reference" : "MedicinalProductDefinition/mp50mg"
          }
        ],
        "administrableDoseForm" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "100000073863",
              "display" : "Solution for injection"
            }
          ]
        },
        "unitOfPresentation" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "200000002150",
              "display" : "Syringe"
            }
          ]
        },
        "producedFrom" : [
          {
            "reference" : "ManufacturedItemDefinition/mid50mg"
          }
        ],
        "routeOfAdministration" : [
          {
            "code" : {
              "coding" : [
                {
                  "system" : "https://spor.ema.europa.eu/rmswi",
                  "code" : "100000073633",
                  "display" : "Subcutaneous use"
                }
              ]
            },
            "targetSpecies" : [
              {
                "code" : {
                  "coding" : [
                    {
                      "system" : "https://spor.ema.europa.eu/rmswi",
                      "code" : "100000109093",
                      "display" : "Human"
                    }
                  ]
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "RegulatedAuthorization/authorization50mg",
      "resource" : {
        "resourceType" : "RegulatedAuthorization",
        "id" : "authorization50mg",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"RegulatedAuthorization_authorization50mg\"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name=\"authorization50mg\"> </a><a name=\"hcauthorization50mg\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource RegulatedAuthorization &quot;authorization50mg&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html\">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/6ae5b5d9-7372-494c-874b-7dc67d386d2e\u00a0(use:\u00a0official)</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp50mg</p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000061)</span></p><p><b>region</b>: Russia <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#RU)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2023-08-16 00:00:00+0000</p><p><b>holder</b>: See on this page: Organization/orgpfizerusinc</p></div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "system" : "https://spor.ema.europa.eu/pmswi",
            "value" : "6ae5b5d9-7372-494c-874b-7dc67d386d2e"
          }
        ],
        "subject" : [
          {
            "reference" : "MedicinalProductDefinition/mp50mg"
          }
        ],
        "type" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "220000000061",
              "display" : "Marketing Authorisation"
            }
          ]
        },
        "region" : [
          {
            "coding" : [
              {
                "system" : "urn:iso:std:iso:3166",
                "code" : "RU",
                "display" : "Russia"
              }
            ]
          }
        ],
        "status" : {
          "coding" : [
            {
              "system" : "http://hl7.org/fhir/publication-status",
              "code" : "active",
              "display" : "Active"
            }
          ]
        },
        "statusDate" : "2023-08-16T00:00:00Z",
        "holder" : {
          "reference" : "Organization/orgpfizerusinc"
        }
      }
    },
    {
      "fullUrl" : "Organization/orgpfizerusinc",
      "resource" : {
        "resourceType" : "Organization",
        "id" : "orgpfizerusinc",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Organization_orgpfizerusinc\"> </a><p><b>Generated Narrative: Organization</b><a name=\"orgpfizerusinc\"> </a><a name=\"hcorgpfizerusinc\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Organization &quot;orgpfizerusinc&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Organization-uv-epi.html\">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/placeholder\u00a0(use:\u00a0official)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000034)</span></p><p><b>name</b>: Pfizer Innovations LLC</p><h3>Contacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Address</b></td></tr><tr><td style=\"display: none\">*</td><td>123112, Moscow, Presnenskaya nab., d. 10, BTs [Business Centre] “Bashnya na Naberezhnoy” (Blok C)(work)</td></tr></table></div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "system" : "https://spor.ema.europa.eu/omswi",
            "value" : "placeholder"
          }
        ],
        "active" : true,
        "type" : [
          {
            "coding" : [
              {
                "system" : "https://spor.ema.europa.eu/rmswi",
                "code" : "220000000034",
                "display" : "Marketing authorisation holder"
              }
            ],
            "text" : "Marketing authorisation holder"
          }
        ],
        "name" : "Pfizer Innovations LLC",
        "contact" : [
          {
            "address" : {
              "use" : "work",
              "type" : "physical",
              "text" : "123112, Moscow, Presnenskaya nab., d. 10, BTs [Business Centre] “Bashnya na Naberezhnoy” (Blok C)",
              "line" : [
                "Presnenskaya Naberezhnaya"
              ],
              "city" : "Moscow",
              "country" : "RU"
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "Organization/orgpfizerbe",
      "resource" : {
        "resourceType" : "Organization",
        "id" : "orgpfizerbe",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Organization_orgpfizerbe\"> </a><p><b>Generated Narrative: Organization</b><a name=\"orgpfizerbe\"> </a><a name=\"hcorgpfizerbe\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Organization &quot;orgpfizerbe&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Organization-uv-epi.html\">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/placeholder\u00a0(use:\u00a0official)</p><p><b>active</b>: true</p><p><b>type</b>: Manufacturer <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#220000000033)</span></p><p><b>name</b>: Pfizer Manufacturing Belgium NV, Belgium</p><h3>Contacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Address</b></td></tr><tr><td style=\"display: none\">*</td><td>12 Rijksweg, 2870 Puurs-Sint-Amands, Belgium(work)</td></tr></table></div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "system" : "https://spor.ema.europa.eu/omswi",
            "value" : "placeholder"
          }
        ],
        "active" : true,
        "type" : [
          {
            "coding" : [
              {
                "system" : "https://spor.ema.europa.eu/rmswi",
                "code" : "220000000033",
                "display" : "Manufacturer"
              }
            ],
            "text" : "Manufacturer"
          }
        ],
        "name" : "Pfizer Manufacturing Belgium NV, Belgium",
        "contact" : [
          {
            "address" : {
              "use" : "work",
              "type" : "physical",
              "text" : "12 Rijksweg, 2870 Puurs-Sint-Amands, Belgium",
              "line" : [
                "12 Rijksweg"
              ],
              "city" : "Puurs-Sint-Amands",
              "country" : "BE"
            }
          }
        ]
      }
    },
    {
      "fullUrl" : "PackagedProductDefinition/ppd50mgsyringe4",
      "resource" : {
        "resourceType" : "PackagedProductDefinition",
        "id" : "ppd50mgsyringe4",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"PackagedProductDefinition_ppd50mgsyringe4\"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name=\"ppd50mgsyringe4\"> </a><a name=\"hcppd50mgsyringe4\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource PackagedProductDefinition &quot;ppd50mgsyringe4&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html\">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab\u00a0(use:\u00a0official)</p><p><b>name</b>: Enbrel four syringe plastic package</p><p><b>type</b>: Biological Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000155530)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp50mg</p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2023-08-16 00:00:00+0000</p><p><b>containedItemQuantity</b>: 50 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/orgpfizerbe</p><h3>Packagings</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td style=\"display: none\">*</td><td><code>https://spor.ema.europa.eu/pmswi</code>/5913fadd-6172-4282-ad02-19ab9d063b66</td><td>Box <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000073498)</span></td><td>4</td><td>Plastic <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#200000003208)</span></td></tr></table></div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "system" : "https://spor.ema.europa.eu/pmswi",
            "value" : "b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab"
          }
        ],
        "name" : "Enbrel four syringe plastic package",
        "type" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "100000155530",
              "display" : "Biological Medicinal Product"
            }
          ]
        },
        "packageFor" : [
          {
            "reference" : "MedicinalProductDefinition/mp50mg"
          }
        ],
        "status" : {
          "coding" : [
            {
              "system" : "http://hl7.org/fhir/publication-status",
              "code" : "active",
              "display" : "Active"
            }
          ]
        },
        "statusDate" : "2023-08-16T00:00:00Z",
        "containedItemQuantity" : [
          {
            "value" : 50,
            "system" : "http://unitsofmeasure.org",
            "code" : "mg"
          }
        ],
        "manufacturer" : [
          {
            "reference" : "Organization/orgpfizerbe"
          }
        ],
        "packaging" : {
          "identifier" : [
            {
              "system" : "https://spor.ema.europa.eu/pmswi",
              "value" : "5913fadd-6172-4282-ad02-19ab9d063b66"
            }
          ],
          "type" : {
            "coding" : [
              {
                "system" : "https://spor.ema.europa.eu/rmswi",
                "code" : "100000073498",
                "display" : "Box"
              }
            ]
          },
          "quantity" : 4,
          "material" : [
            {
              "coding" : [
                {
                  "system" : "https://spor.ema.europa.eu/rmswi",
                  "code" : "200000003208",
                  "display" : "Plastic"
                }
              ]
            }
          ]
        }
      }
    },
    {
      "fullUrl" : "MedicinalProductDefinition/mp50mg",
      "resource" : {
        "resourceType" : "MedicinalProductDefinition",
        "id" : "mp50mg",
        "meta" : {
          "profile" : [
            🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_mp50mg\"> </a><p><b>Generated Narrative: MedicinalProductDefinition</b><a name=\"mp50mg\"> </a><a name=\"hcmp50mg\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicinalProductDefinition &quot;mp50mg&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-MedicinalProductDefinition-uv-epi.html\">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://www.mhra.gov.uk/</code>/471bb15-7f52-4fcd-b615-8674ce6eb91e</p><p><b>type</b>: Medicinal Product <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-medicinal-product-type.html\">Medicinal Product Type</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-medicinal-product-domain.html\">Medicinal Product Domain</a>#Human)</span></p><p><b>status</b>: active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Enbrel (etanercept) 50 mg/ml solution for subcutaneous injection</p><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td>Russia <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#RU)</span></td><td>Russia <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html\">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#RU)</span></td><td>Russian <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html\">Tags for the Identification of Languages</a>#ru)</span></td></tr></table></blockquote></div>"
        },
        "identifier" : [
          {
            "system" : "http://www.mhra.gov.uk/",
            "value" : "471bb15-7f52-4fcd-b615-8674ce6eb91e"
          }
        ],
        "type" : {
          "coding" : [
            {
              "system" : "http://hl7.org/fhir/medicinal-product-type",
              "code" : "MedicinalProduct",
              "display" : "Medicinal Product"
            }
          ]
        },
        "domain" : {
          "coding" : [
            {
              "system" : "http://hl7.org/fhir/medicinal-product-domain",
              "code" : "Human",
              "display" : "Human use"
            }
          ]
        },
        "status" : {
          "coding" : [
            {
              "system" : "http://hl7.org/fhir/publication-status",
              "code" : "active",
              "display" : "active"
            }
          ]
        },
        "legalStatusOfSupply" : {
          "coding" : [
            {
              "system" : "https://spor.ema.europa.eu/rmswi",
              "code" : "100000072084",
              "display" : "Medicinal product subject to medical prescription"
            }
          ]
        },
        "name" : [
          {
            "productName" : "Enbrel (etanercept) 50 mg/ml solution for subcutaneous injection",
            "usage" : [
              {
                "country" : {
                  "coding" : [
                    {
                      "system" : "urn:iso:std:iso:3166",
                      "code" : "RU",
                      "display" : "Russia"
                    }
                  ]
                },
                "jurisdiction" : {
                  "coding" : [
                    {
                      "system" : "urn:iso:std:iso:3166",
                      "code" : "RU",
                      "display" : "Russia"
                    }
                  ]
                },
                "language" : {
                  "coding" : [
                    {
                      "system" : "urn:ietf:bcp:47",
                      "code" : "ru",
                      "display" : "Russian"
                    }
                  ]
                }
              }
            ]
          }
        ]
      }
    }
  ]
}